The structure of SpoVT by Asen, Iris
 
 
Dissertation 
 
zur Erlangung des Doktorgrades der Fakultät für Chemie und Pharmazie 
der Ludwig-Maximilians-Universität München 
 
 
 
 
 
 
 
 
 
 
THE STRUCTURE OF SPOVT 
 
A REGULATOR OF SPORULATION IN BACILLUS SUBTILIS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Iris Asen 
 
aus 
Vilshofen 
 
 
 
2008 

 
 
 
Erklärung 
 
Diese Dissertation wurde im Sinne von § 13 Abs. 3 der Promotionsordnung vom 
29. Januar 1998 von Herrn Prof. Dieter Oesterhelt betreut. 
 
 
 
 
 
 
 
 
Ehrenwörtliche Versicherung 
 
Diese Dissertation wurde selbständig, ohne unerlaubte Hilfe erarbeitet. 
 
 
 
 
München, am 15.05.2008 
 
 
 
 
 
 
Iris Asen 
 
 
 
 
 
 
 
 
 
Dissertation eingereicht am  15.05.2008 
 
1. Gutachter       Prof. Dieter Oesterhelt 
 
2. Gutachter       Prof. Karl-Peter Hopfner 
 
Mündliche Prüfung am   31.07.2008 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Für den gläubigen Menschen steht Gott am Anfang, 
für den Wissenschaftler am Ende aller seiner Überlegungen. 
 
 
Max Planck 
 
Table of contents 
TABLE OF CONTENTS 
 
 
 
1. SUMMARY/ZUSAMMENFASSUNG ..................................................................5 
2. INTRODUCTION......................................................................................7 
2.1 Cellular Differentiation – Basics and Features .............................................. 7 
2.2 Sporulation in Bacteria ................................................................................. 8 
2.3 Endospores ................................................................................................... 9 
2.4 Endospore Formation in Bacillus subtilis ..................................................... 10 
2.4.1 σ– and Transcription Factors .................................................................... 12 
2.4.2 σG-dependent Transcription Factor SpoVT................................................ 15 
2.5 Scope of Work............................................................................................. 19 
3. RESULTS.............................................................................................20 
3.1 Overexpression and Purification of B. subtilis SpoVT ................................... 20 
3.1.1 SpoVT Full-length....................................................................................... 20 
3.1.2 C-terminal Domain of SpoVT .................................................................... 21 
3.2 Biochemical Analysis of B. subtilis SpoVT .................................................... 21 
3.2.1 Secondary Structure and Thermal Stability ............................................... 21 
3.2.2 Oligomeric Form ...................................................................................... 24 
3.2.2.1 Covalent Linkage....................................................................................................... 24 
3.2.2.2 Native State................................................................................................................ 25 
3.2.3 Immunological Detection of Native SpoVT............................................... 26 
3.2.3.1 Generation of Polyclonal Rabbit Anti-SpoVT Antibodies.............................................. 26 
3.2.3.2 Purification of Polyclonal Anti-SpoVT Antibodies.......................................................... 27 
3.2.3.3 Synchronisation of B. subtilis Cells and Induction of Sporulation................................. 28 
3.2.3.4 Immuno Blotting......................................................................................................... 29 
3.3 3D-Crystallisation and Structural Analysis of B. subtilis SpoVT..................... 31 
3.3.1 X-ray Crystallography................................................................................ 31 
3.3.2 Phasing and Density Fitting....................................................................... 34 
3.3.3 Model Building and Structural Refinement ............................................... 35 
3.4 Structure of B. subtilis SpoVT ....................................................................... 37 
3.4.1 Crystal Packing ......................................................................................... 37 
3.4.2 Overall Fold of Tetrameric Complex......................................................... 38 
3.4.3 Asymmetric Tetramer................................................................................ 40 
3.4.4 Two Different Monomers ........................................................................... 42 
3.4.5 Multimerisation Modules ........................................................................... 43 
3.4.5.1 N-terminal Domain..................................................................................................... 43 
3.4.5.2 C-terminal Domain .................................................................................................... 45 
3.4.6 Novel Domain Architecture ...................................................................... 47 
3.4.6.1 Swapped-hairpin β-barrel........................................................................................... 47 
3.4.6.2 GAF Domain .............................................................................................................. 49 
3.4.7 New Dimerisation Mode of GAF Domains ................................................ 51 
3.5 DNA- and Ligand Binding Studies of B. subtilis SpoVT ................................. 53 
3.5.1 Biochemical Approach ............................................................................ 53 
3.5.1.1 Limited Proteolysis with Trypsin and α-Chymotrypsin ................................................... 53 
3.5.1.2 Gel Filtration Chromatography................................................................................... 54 
3.5.2 Biophysical Approach .............................................................................. 55 
3.5.2.1 Co-crystallisation and Soaking ................................................................................... 55 
3.5.2.2 Isothermal Titration Calorimetry (ITC)........................................................................... 56 
 1
Table of contents 
4. DISCUSSION .......................................................................................57 
4.1 Tetrameric State of B. subtilis SpoVT ........................................................... 57 
4.1.1 Biochemical Aspects................................................................................ 57 
4.1.2 Structural Aspects ..................................................................................... 59 
4.2 DNA-binding Domain (DBD) of B. subtilis SpoVT .......................................... 62 
4.3 Signal Sensing Domain (SSD) of B. subtilis SpoVT ........................................ 65 
4.4 Dimerisation Mode of GAF Domains in B. subtilis SpoVT............................. 68 
4.5 Model for SpoVT Mediated Regulation ....................................................... 70 
5. MATERIALS .........................................................................................72 
5.1 Chemicals and Reagents ........................................................................... 72 
5.2 Kits and Materials ....................................................................................... 73 
5.3 Media, Buffers, and Solutions...................................................................... 74 
5.3.1 Growth Media........................................................................................... 74 
5.3.1.1 LB Medium ................................................................................................................. 74 
5.3.1.2 TB Medium ................................................................................................................. 74 
5.3.1.3 DSM Medium ............................................................................................................. 75 
5.3.1.4 LB Agar Plates............................................................................................................. 75 
5.3.2 Buffers ....................................................................................................... 76 
5.3.3 Solutions.................................................................................................... 77 
5.4 Strains, Plasmids, and Oligonucleotides..................................................... 78 
5.4.1 Strains ....................................................................................................... 78 
5.4.2 Vector....................................................................................................... 78 
5.4.3 Oligonucleotides ...................................................................................... 79 
5.5 Instruments and Devices............................................................................. 80 
5.6 Computational Software............................................................................. 82 
6. METHODS ..........................................................................................83 
6.1 Molecular Biology and Microbiology.......................................................... 83 
6.1.1 Molecular Biological Methods .................................................................. 83 
6.1.1.1 Amplification of SpoVT Operon DNA Sequence by Polymerase Chain Reaction     
(PCR) ........................................................................................................................... 83 
6.1.1.2 Isolation and Purification of Vector DNA from E. coli .................................................. 84 
6.1.1.3 Determination of DNA Concentration ........................................................................ 84 
6.1.1.4 DNA Sequencing........................................................................................................ 84 
6.1.2 Microbiological Methods.......................................................................... 85 
6.1.2.1 Transformation of Chemically Competent E. coli Cells.............................................. 85 
6.1.2.2 Long-term Stock Cultures ........................................................................................... 85 
6.1.2.3 Cultivation of E. coli and B. subtilis ............................................................................. 86 
6.1.2.4 Synchronisation of B. subtilis Cells............................................................................... 86 
6.1.2.5 Induction of Endospore Formation in B. subtilis .......................................................... 86 
6.1.2.6 Determination of Cell Density..................................................................................... 87 
6.1.2.7 Growth Curve of Bacteria in Liquid Cultures ............................................................... 87 
6.1.2.8 Staining of Endospores............................................................................................... 87 
6.2 Protein Chemistry........................................................................................ 88 
6.2.1 Heterologous Overexpression of Proteins in E. coli.................................... 88 
6.2.2 Purification of His-tagged Proteins from E. coli under Native Conditions .. 88
6.2.3 Generation of Polyclonal Rabbit Antibodies............................................. 89 
6.2.4 Purification of Polyclonal Antibodies ......................................................... 90 
6.2.5 Fast Cell Lysis for Determination of Protein Content.................................. 90 
6.2.6 SDS-Polyacrylamide Gel Electrophoresis .................................................. 91 
6.2.7 Native Polyacrylamide Gel Electrophoresis .............................................. 92 
6.2.8 Electro Blotting.......................................................................................... 92 
2 
Table of contents 
6.2.9 Immuno (Western) Blotting........................................................................ 93 
6.2.10 Dialysis .................................................................................................... 93 
6.2.11 Ultrafiltration ............................................................................................ 94 
6.2.12 Determination of Protein Concentration................................................. 94 
6.2.12.1 UV Absorption........................................................................................................... 94 
6.2.12.2 BCA Protein Essay ..................................................................................................... 95 
6.2.13 Chemical Crosslinking ............................................................................ 95 
6.3 Biochemistry................................................................................................ 96 
6.3.1 Chromatography ..................................................................................... 96 
6.3.1.1 Affinity Chromatography ............................................................................................ 96 
6.3.1.2 Gel Filtration Chromatography................................................................................... 96 
6.3.2 High Performance Liquid Chromatography/Mass Spectrometry    
(HPLC/MS) ................................................................................................. 97 
6.3.3 Matrix Assisted Laser Desorption Ionisation/Time of Flight/Mass 
Spectrometry (MALDI/TOF/MS)................................................................... 97 
6.3.4 N-terminal Amino Acid Sequencing ......................................................... 98 
6.3.5 Limited Proteolysis..................................................................................... 98 
6.3.6 Preparation of B. subtilis Spores ................................................................ 98 
6.4 Molecular Biophysics .................................................................................. 99 
6.4.1 X-ray Crystallography................................................................................ 99 
6.4.1.1 Protein Crystallisation, Soaking, Co-crystallisation, and Seeding................................. 99 
6.4.1.2 Crystal Mounting and Data Collection ..................................................................... 100 
6.4.1.3 Data Processing and Phasing .................................................................................. 101 
6.4.1.4 Model Building and Refinement............................................................................... 101 
6.4.2 Circular Dichroism (CD) Spectroscopy.................................................... 102 
6.4.3 Isothermal Titration Calorimetry (ITC) ....................................................... 102 
7. ABBREVIATIONS..................................................................................103 
8. REFERENCES .....................................................................................105 
9. APPENDIX ........................................................................................110 
10. ACKNOWLEDGEMENT - DANKSAGUNG ...................................................112 
11. CURRICULUM VITAE ..........................................................................114 
 3

Summary 
1. SUMMARY/ZUSAMMENFASSUNG 
 
 
Adaptation to environmental changes is essential for the survival or at least for the 
continuity of the genetic material of every organism. Some cells adjust to alternating 
conditions on the basis of cellular differentiation. Gram-positive organisms, such as 
Bacillus subtilis, adapt to unfavourable conditions by protecting their genome in robust 
endospores. Sporulation is a complex and tightly balanced cell differentiation 
programme which controls highly specific temporal and spatial gene expression. In 
B. subtilis, endospore formation is orchestrated by five developmental alternative sigma 
factors and further modulated by several auxiliary transcription factors. One of these, 
SpoVT, regulates forespore-specific σG-dependent genes and plays a key role in the 
final stages of spore formation. 
 
This work introduces the crystal structure of B. subtilis SpoVT comprising a novel domain 
architecture in transcription factors. The structures of the full-length SpoVT protein and, 
separately, of its isolated C-terminal domain were determined at 2.6 Å and 1.5 Å, 
respectively. SpoVT is a tetramer in which the N-terminal domains dimerise to build 
swapped-hairpin β-barrels and the dimers further assemble through helical interactions 
between their C-terminal domains. A tetrameric oligomer of SpoVT is supported by 
biochemical results. 
By structure and sequence comparisons between swapped-hairpin β-barrels, a 
predicted close relationship to the transition state regulator AbrB is confirmed. Structural 
analysis of the C-terminal domain proves a bioinformatically predicted GAF fold and 
shows a further homology to the protein CodY. The described helical interaction 
between the C-terminal domains presents a new mode of dimer formation in GAF 
domains. 
The SpoVT tetramer is characterised by an overall asymmetry due to an anti-parallel 
assembly of two conformationally differing monomers. Structural investigations show a 
certain degree of flexibility between the domains in the asymmetric tetramer. 
Based on those structural data, it is hypothesised that SpoVT is a GAF domain regulated 
transcription factor whose DNA-binding activity is controlled by sensing a yet unknown 
small molecule. 
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Zusammenfassung 
Für jeden Organismus ist es essentiell sich an die sich ständig verändernden Umwelt-
bedingungen anzupassen, um sein Überleben oder zumindest den Fortbestand seines 
genetischen Materials zu sichern. Manche Zellen gleichen sich durch Spezialisierung an, 
wobei sie den Prozeß der Zelldifferenzierung durchlaufen. Gram-positive Organismen 
wie Bacillus subtilis schützen ihr Genom vor ungünstigen Umweltbedingungen in 
robusten Endosporen. Der Sporulationsprozess ist ein komplexes und streng reguliertes 
Zelldifferenzierungsprogramm, welches die zeitlich und räumlich hoch spezifische 
Genexpression kontrolliert. Die Endosporenbildung in B. subtilis wird von fünf alternativen 
Sigmafaktoren koordiniert und von mehreren unterstützenden Transkriptionsfaktoren 
weiter moduliert. Als einer von diesen, reguliert SpoVT vorsporentypische σG-abhängige 
Gene und hat eine Schlüsselfunktion in den finalen Stadien der Sporenentwicklung. 
 
Diese Arbeit beschreibt die Kristallstruktur von B. subtilis SpoVT und zugleich eine 
neuartige Bauweise von Transkriptionsfaktoren. Die Struktur des volllängen SpoVT Proteins 
wurde bei 2.6 Å bestimmt und die der isolierten C-terminalen Domäne gesondert bei 
1.5 Å. SpoVT ist ein Tetramer, in welchem die N-terminalen Domänen dimerisieren, um 
ein „swapped hairpin β-barrel“ zu formen und die Dimere durch helikale Interaktionen 
zwischen ihren C-terminalen Domänen weiter assemblieren. Der tetramere 
Oligomerisierungszustand von SpoVT wird auch von biochemischen Daten untermauert. 
Anhand von Struktur- und Sequenzvergleichen zwischen „swapped hairpin β-barrels“, 
wird die vorhergesagte enge Verwandtschaft zu dem Übergangsregulator AbrB 
bestätigt. Die Strukturanalyse der C-terminalen Domäne weist einen durch 
bioinformatische Methoden vorhergesagten GAF-Faltungstyp nach und es wird eine 
gewisse Homologie zu dem Protein CodY gezeigt. Die Art der Interaktion zwischen Helix-
Bündel zweier SpoVT GAF-Domänen beschreibt einen neuen Modus der Dimer-
Formation innerhalb der Gruppe der GAF-Domänen. 
Das SpoVT Tetramer ist charakterisiert durch eine Asymmetrie, die auf einer 
antiparallelen Anordung von zwei konformell zu unterscheidenden Monomeren basiert. 
Strukturuntersuchungen legen einen gewissen Grad an Flexibilität zwischen den 
Domänen innerhalb des asymmetrischen Tetramers dar. 
Aufgrund dieser strukturellen Daten wurde die Hypothese erstellt, dass SpoVT ein von 
GAF-Domänen regulierter Transkriptionsfaktor ist, dessen DNA-Bindeaktivität durch 
Detektieren eines bisher unbekannten kleinen Moleküls gesteuert wird. 
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2. INTRODUCTION 
 
 
2.1 Cellular Differentiation – Basics and Features 
 
Organisms are complex living systems whose viability is based on the interplay of their 
functional components. They are in a permanent close relationship to the environment 
and, consequently, a sophisticated strategy to adapt to continuously changing 
conditions is of prime importance in evolution. Adaptation in long-term respects 
proceeds in species and genera over many generations called phyletic adaptation. 
Individual adaptation in turn, occurs in single individuals as a relatively rapid progress. 
Such processes always come along with a great effort in reorganisation and 
restructuring the working system focussing on the continuity of the genetic material. 
Changing the actual constitution is based on a highly controlled action of specific 
genes and proteins and can generate a new type of cell presenting completely new 
functions. This complex developmental procedure is termed cellular differentiation. 
Cellular differentiation describes the transition by which an unspecialised cell becomes 
a specialised cell (Fig. 1). Under such a transition, a cell may alter dramatically; size, 
shape, polarity, metabolic activity, sensitivity to signals, and gene expression profiles 
can change during differentiation. For single cell organisms, this probably means that 
they convert into a different life-form. 
 
 
Signal or Intrinsic
Programme
Unspecialised Cells
Signal
Specialised Cells
Cellular
DifferentiationSignal
 
 
Figure 1. Schematic Illustration of the General Basic Task of Cellular Differentiation. Specific incoming signals 
(left) turn on specific cellular programmes (middle) and lead to corresponding modifications of the cell (right). 
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Cells affected by an environmental stimulus start a tightly balanced signal or intrinsic 
programme (Fig. 1) which leads to a modified gene expression profile. Cellular 
differentiation is primarily characterised by a differing gene activity in cells. During the 
differentiation progress, specific genes are up-regulated while other genes are down-
regulated. Genes instruct how and when to build the proteins that allow the cell to 
create new structures and functions. Thereby, the proteins in one cell differ from those in 
another cell. The coordination of well timed activation and inactivation of genes is 
intricately regulated and to date, little understood. Studies on cell differentiation 
processes in lower life-forms might provide an insight into this complex interaction 
network. 
 
 
 
2.2 Sporulation in Bacteria 
 
Sporulation is a process in lower life-forms (fungi, moss, ferns, algae, and protozoans) 
which leads to a distinct developmental stage, featuring a high stress resistance with 
the intention of reproduction or survival. 
The spore formation procedure in Bacteria describes a relatively simple form of cell 
differentiation. Some bacteria, e.g. the genera of Methylosinus or Methylocystis develop 
exospores (Whittenbury et al., 1970). This type of spore is aimed to reproduce and arises 
from pullulation. Spores of Actinobacteria are generated in characteristic filaments 
(Cavalier-Smith, 1987) and function in reproduction, also. Myxobacteria form spores 
within their fruiting bodies (Dworkin and Kaiser, 1993). The myxospores are coated by a 
thick cell wall and represent resistant dormant bodies. Comparable strategies are 
pursued by cyst formation in Azotobacter (Wyss et al., 1961). 
For survival, a group of bacteria generates single endospores internally which are not 
able to reproduce and by far present the most resistant type of spores. Endospore 
formation as survival strategy occurs in the families Bacillaceae, Clostridiaceae, 
Peptococcaceae, Heliobacteriaceae, Oscillospiraceae, and Thermoactinomyceta-
ceae. All families are placed within the classes Bacilli and Clostridia which are included 
in the phylum Firmicutes. Together with Actinobacteria, both phyla gather Gram-
positive bacteria which feature a significant thick cell wall (peptidoglycan; covalently 
8 
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linked N-acetlymuramic acid and N-acetylglucosamine) instead of an outer 
membrane. 
Consistently, endospore-forming organisms are Gram-positive bacteria. 
 
 
 
2.3 Endospores 
 
Endospore formation is a process at which a vegetative cell is converted into a non-
growing, non-reproductive, and highly resistant structure (Bender and Marquis, 1985; 
Piggot and Hilbert, 2004; Slepecky and Leadbetter, 1994). Endospores are resistant to 
desiccation (including vacuum), temperature, ultraviolet and gamma radiation, 
starvation, most disinfectants, or oxidising agents. 
The typical architecture of an endospore is: cytoplasma with DNA and ribosomes, 
plasma membrane, cell wall, and capsule. Endospores are dehydrated (10-30% of 
water content of vegetative cells), metabolically inactive cells with an unusually high 
content of calcium dipicolinate (~ 10% of its dry weight) which is assumed to stabilise 
the densely packed DNA. 
Several resistant dormant forms of endospores are known: centrally (Fig. 2a and Fig. 2b 
with distention of the mother cell), terminally (Fig. 2c and Fig. 2d and 2e with distention 
of the mother cell), and laterally arranged (Fig. 2f with distention of the mother cell). 
 
 
a c db fe  
 
Figure 2. Intracellular Location of Endospores. (a) central (B. megaterium), (b) central, mother cell fusiform 
swollen (B. polymyxa), (c) terminal (B. thuringiensis), (d) terminal, mother cell swollen (B. macerans), (e) terminal, 
mother cell drummstick-shaped swollen (B. sphaericus), and (f) lateral, mother cell fusiform swollen 
(B. laterosporus) (modified from Fuchs and Schlegel, 2006)). 
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Formation of endospores proceeds as a multistage differentiation programme induced 
upon nutrient starvation and stress exposure (Sonenshein et al., 1993). Cultures of Gram-
positive bacteria develop endospores during the vegetative growth cycle at the 
transition to stationary phase, for instance. Thereby, lack of food is the initiating signal to 
start the sporulation process. 
 
Regulation of cell differentiation is mediated by extra- and intra-cellular signals. The two-
component system (phosphorelay) senses the primary environmental stimuli and is 
further implicated in signal transduction and cellular response (Hoch, 1993). Following 
stages of morphogenesis, which generate the mother and the daughter cell (the spore) 
are governed mainly by alternative sigma factors. Alternative σ–factors only become 
active while the cell is exposed to extraordinary circumstances. As part of the RNA 
polymerase (RNAP), σ–factors recognise specific promoters and initiate transcription of 
required genes. 
 
 
 
2.4 Endospore Formation in Bacillus subtilis 
 
Bacillus subtilis is a Gram-positive organism which exhibits the ability to adapt to 
unfavourable conditions by protecting its genome in robust endospores by sporulation 
(Errington, 2003; Sonenshein et al., 1993). Endospore formation in B. subtilis is a complex 
seven-step cell differentiation process (Fig. 3) (Errington, 2003). After replication of the 
DNA, in stage I, septum formation begins near each of the poles of the vegetative cell, 
denoted as the predivisional cell. The DNA condenses while the septum at one side of 
the predivisional cell stops its further development. Two different cells are generated by 
asymmetrical division of the vegetative cell: the mother cell and the prespore (stage II). 
In stage III, the prespore is engulfed by the mother cell. The small compartment is then 
surrounded by a double membrane. From this stage on, the prespore is termed 
forespore. In the mother cell the DNA decomposes while in the forespore chamber it 
becomes dense during association with small acid-soluble spore proteins (SASP) for 
protection. At this time, the forespore dehydrates and calcium dipicolinate is 
incorporated. Stage IV is designated by the formation of the cortex which consists of a 
10 
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modified form of peptidoglycan and is synthesised between the membranes which 
separate the cells. A second protective layer, the coat, composed of approximately 50 
different proteins, is arranged around the forespore in stage V. Maturation and 
eventually release of the spore by lysis of the mother cell (stage VI and VII) completes 
the sporulation cycle (Fig. 3) (Errington, 2003; Wang et al., 2006). 
 
 
Vegetative Cell
VEGETATIVE CYCLE
Medial
Division
SPORULATION
Asymmetric
Division
Growth
Germination
Spore Engulfment
Mother Cell Lysis
Coat Formation
Cortex Formation
Stage 0
Stage II
Stage I
Stage III
Stage IV
Stage V
Stage VI
Stage VII
 
 
Figure 3. Stages in Endospore Formation and Vegetative Cell Cycle of B. subtilis. Simplified schematic 
representation of vegetative reproduction of a B. subtilis cell (left, green) compared to its sporulation cycle 
during endospore formation (right, red) (created on the basis of Brock et al., 1994). 
 
 
This alternate life-form can remain dormant for many years. The appearance of 
beneficial conditions converts the endospore back into a vegetative cell by 
germination and growth which then is capable of entering the vegetative life cycle 
(Fig. 3). 
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2.4.1 σ– and Transcription Factors 
 
The cell differentiation process leading to endospore formation in B. subtilis is controlled 
by the action of five alternative sigma factors which regulate gene transcription in a 
temporal and cell-type specific manner (Errington, 2003; Wang et al., 2006). In 
B. subtilis, there are at least 17 different alternative σ-factors known which are dedicated 
to different promoter specificities and trigger changes in the pattern of gene expression 
(Kunst et al., 1997). 
 
At an early stage of sporulation, in the predivisional cell σH is required which directly 
activates transcription of certain sporulation genes, e.g. the master regulator for entry 
into sporulation Spo0A (Britton et al., 2002). In the prespore, the sigma factor σF 
becomes active, immediately followed by the activation of σE in the mother cell. The 
concerted action of σF and σE between the mother and the prespore cell line is 
implicated in the correct asymmetric division progress during differentiation in B. subtilis 
(Errington, 2003; Wang et al., 2006). 262 genes are switched on under σE control, 48 
genes are regulated by the prespore-specific σF-factor (Wang et al., 2006). In turn, 
another σ-factor in the prespore is released: σG, which governs the engulfment event 
and influences expression of 95 regulatory and structural genes. σK is the final mother 
cell-specific sigma factor and decisive in the late stage of spore development by 
turning on ~ 75 genes. Throughout the action of the inter-connected programmes 
between the two different cell compartments, the expression level of 504 genes is 
affected (Wang et al., 2006). 
 
Further modulation of gene expression within each of these regulons is achieved by 
additional specific transcriptional regulators. Specific transcription factors are necessary 
to mediate RNAP´s gene transcription specificity by recruiting the attached σ-factors. In 
contrast, general transcription factors show a wide variety of activity in regulating gene 
expression. 
 
For the sporulation-specific transcription factors SpoIIID, GerE, RsfA, and SpoVT, a direct 
dependence on σE, σK, σF, and σG, respectively, was determined (Steil et al., 2005; 
Wang et al., 2006) (Fig. 4). 
12 
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Figure 4. Interplay of σ- and Transcription Factors during Sporulation in B. subtilis. Regulatory circuits for the 
predivisional cell, the forespore, and the mother cell governing sporulation (Wang et al., 2006). AND gates are 
indicated. 
 
 
Transcription factors play an important role during the differentiation process since they 
are the ultimate targets of signal-transduction pathways. Finally, the specific 
transcription factors regulate endospore formation by binding to a specific DNA site (or 
set of sites) and thus control the expression of genes (Stragier and Losick, 1996). 
Transcription factors can act as inducers or repressors and as activators. Repressors bind 
to DNA and block transcription of a gene, whereas inducers enable gene transcription 
by dissociation from DNA. Activating transcription factors enhance the affinity of RNAP to 
DNA by binding to the activator site which is close to the promoter. In case of far 
distance between activator site and promoter, association of the transcription factor to 
DNA enforces DNA looping and thereby allows RNAP to form correct contacts with the 
promoter region. 
For the regulation of the transcription factors itself, there are two levels which can be 
influenced: the synthesis and the activity of the transcription factor. The rate of synthesis 
controls the available concentration of the transcription factor. Chemical (post-
translational) modification, ligand binding, dimerisation, interactions with co-factors, etc. 
govern the activity of the transcription factor and affect its DNA-binding affinity. 
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Activity regulated transcription factors often show a typical assembly composed of a 
DNA binding domain (DBD), a ligand binding domain or a signal sensing domain (SSD), 
and occasionally a trans-activation domain (TAD); the latter for binding to other proteins. 
Transcription factors of B. subtilis are at least two-domain proteins offering a DBD (mostly 
N-terminal) and a multimerisation domain/SSD (often C-terminal) as a result of diverse 
duplication events (Moreno-Campuzano et al., 2006). 
 
DBDs mostly bind to palindromic or tandem repeats of DNA called transcription factor 
binding site or response element. In the majority of cases, transcription factors are 
dimeric, mostly homodimeric, predestined to bind to two consecutive major grooves of 
the DNA-binding site which usually spans a region of ~ 20 base pairs (bp). In bacteria, 
the most common DBD structure motif is the so-called winged helix-turn-helix (HTH) motif 
(Fig. 5a, (Zhao et al., 2002)). Others, like the Zinc-finger (ZnF), helix-loop-helix (HLH), RNA-
binding-like domains, and β-sheet anti-parallel DBD (Fig. 5b, (Newman et al., 1998)) are 
present in a significantly minor proportion (Pabo and Sauer, 1992; Pérez-Rueda and 
Collado-Vides, 2000; Pérez-Rueda et al., 2004). 
DNA-binding via α-helices is based on shape and size most suitable for docking into the 
major groove of B-DNA (Pabo and Sauer, 1992). Usually, the recognition helix of the HTH 
structure adapts to the major groove of DNA while the second helix supports the 
positioning of the first helix and stabilises the interaction (Fig. 5a). 
 
 
 
a b 
 
Figure 5. DNA-Binding Structure Motifs. Crystal structure of dimeric (a) effector domain of B. subtilis Spo0A 
presenting a winged HTH DBD (PDB 1LQ1) coloured by monomers and (b) type II restriction endonuclease BglI of 
B. globigii showing a β-sheet anti-parallel DBD (PDB 1DMU) coloured according to secondary structure elements, 
each in complex with its target DNA (left in element colour coded sticks, right cartoon presentation in blue). 
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In B. subtilis, 47% of the whole transcription factor repertoire contains a winged HTH DBD. 
The transcription factors of B. subtilis are classified into 51 different families (based on 
HMM search and PFAM) presenting a broad variety in the number of family members 
(Moreno-Campuzano et al., 2006). 19 families include only one member and are 
presumably important in specific cellular processes. These are for sporulation and 
related procedures e.g. two families which specify each one of the global regulators 
AbrB and CodY (Moreno-Campuzano et al., 2006). 
 
 
2.4.2 σG-dependent Transcription Factor SpoVT 
 
Recently, the σG-dependent transcription factor SpoVT was grouped into the newly 
defined class of AbrB-like transcription factors (Coles et al., 2005). Members of the large 
superfamily are characterised by their DBD which folds into an anti-prarallel β-barrel. A 
precise understanding of the interaction mode between this new structural DBD motif 
and DNA is missing because of the lack of structural data. 
B. subtilis SpoVT coordinates gene expression in the small forespore chamber, which is 
destined to become the mature dormant spore. SpoVT not only acts as a 
transcriptional activator, but also as a repressor, whereupon the expression level of 
47 genes is affected (Wang et al., 2006). Most of these are of unknown function but 
also include a spore cortex-lytic enzyme (sleB), a sporulation specific SASP (csgA), and 
germination response receptors which are repressed by SpoVT (Igarashi and Setlow, 
2006; Wang et al., 2006). Genes coding for e.g. flavohemoglobin (hmp), a spore 
cortex protein (coxA), and SASPs are activated by SpoVT (Wang et al., 2006). In addition, 
for the expression of the SpoVT regulator itself, auto-regulation by binding to its own 
promoter region in association with σG is noted (Dong et al., 2004) (Fig. 6). 
 
 
attttgttactctctggTGTATATtacatttgatgtgacgGATACTAATttcaagcgaggcggaaggtacataaa 
 
gtaactgctttaggtctttcccacatgtatataccatcaaatgaaagagaggcaccagagatgaaagcaaccggt 
                                                             M  K  A  T  G 
 
Figure 6. Promoter Region of B. subtilis spoVT. -35 and -10 regions of spoVT promoter are highlighted in bold 
and red capital letters, ribosome binding site is shown in bold green. Start point of transcription is in bold orange 
and orientation is shown by an arrow. Blue letters indicate start of SpoVT protein coding sequence. 
Corresponding amino acids are in bold blue capital letters (modified from Bagyan et al., 1996). 
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B. subtilis spoVT mutants have a poorly assembled spore coat (Fig. 7) and are 
germination defective (Bagyan et al., 1996; Le Breton et al., 2006). SpoVT thus plays an 
indispensable role in the late stage (stage V) of spore formation and, hence, assures 
survival of the genetic information. 
 
 
 
 
Figure 7. SpoVT Mutant Sporangium. EM micrograph of mature (a) wild type and (b, c) mutant spores in 
B. subtilis cells. Outer coat layer of wild type spores appears in black while absent in mutant spores. In c, 
misassembled coat material conglomerates at one of the poles (Bagyan et al., 1996). 
 
 
 
SpoVT of B. subtilis is a protein of 178 amino acids (Fig. 8a), with a molecular weight of 
19.7 kDa. SpoVT contains two domains: an N-terminal DBD (residues 1-48) and a C-
terminal domain which is much larger (residues 56-178), unique, and obviously 
important for the structure and function of SpoVT (Dong et al., 2004). The domains are 
connected by a linker comprising the amino acids 49-55 (Fig. 8b). 
16 
Introduction 
  a
1                                                                                           75 
atgaaagcaaccggtatcgtacgtcgtattgatgacttaggtcgggtcgtgattcctaaagaaattcgaagaact 
 1                                                                                         25 
 M  K  A  T  G  I  V  R  R  I  D  D  L  G  R  V  V  I  P  K  E  I  R  R  T  
76                                                                                         150 
ctgagaatcagggaaggcgatccgcttgagatttttgtagatcgtgacggagaagtgattttgaaaaagtactct 
 26                                                                                        50 
 L  R  I  R  E  G  D  P  L  E  I  F  V  D  R  D  G  E  V  I  L  K  K  Y  S  
151                                                                                        225 
ccgatcagtgagcttggagactttgcaaaggagtatgcagacgcgctttacgacagcctcggccattcagtgctg 
 51                                                                                        75 
 P  I  S  E  L  G  D  F  A  K  E  Y  A  D  A  L  Y  D  S  L  G  H  S  V  L  
226                                                                                        300 
atttgtgatcgtgatgtatatattgccgtgtccggcagctccaaaaaagattacttaaacaagtcaatcagcgaa 
 76                                                                                        100 
 I  C  D  R  D  V  Y  I  A  V  S  G  S  S  K  K  D  Y  L  N  K  S  I  S  E  
301                                                                                        375 
atgctggaaagaacaatggatcagcgcagctccgtgcttgagagtgatgcgaaatcagtacagcttgtgaatgga 
 101                                                                                       125 
 M  L  E  R  T  M  D  Q  R  S  S  V  L  E  S  D  A  K  S  V  Q  L  V  N  G  
376                                                                                        450 
attgatgaggacatgaattcttatactgtaggcccaattgtggcgaacggtgatccgataggtgctgtggtgatc 
 126                                                                                       150 
 I  D  E  D  M  N  S  Y  T  V  G  P  I  V  A  N  G  D  P  I  G  A  V  V  I  
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 151                                                                                       175 
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526          537 
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Figure 8. Sequence and Schematic Domain Organisation of B. subtilis SpoVT. (a) DNA (small letters) and 
amino acid (capital letters in bold blue) sequence of B. subtilis SpoVT. (b) Schematic illustration of the domain 
organisation of B. subtilis SpoVT. Residues defining the domains are indicated. 
 
 
The DBD of SpoVT has 68% sequence identity (80% similarity) with the N-terminal region 
of the transcription regulator AbrB (Dong et al., 2004), a key transition state regulator of 
B. subtilis that acts during the transition from vegetative growth to sporulation (Strauch et 
al., 2005). SpoVT thus belongs to the superfamily of swapped-hairpin transcription 
factors which fold into homo-dimeric β-barrels via four pairs of interleaved β-hairpins 
(Benson et al., 2002). 
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The C-terminal domain of SpoVT was predicted by sequence comparisons to be a GAF 
(cGMP-specific and -stimulated phosphodiesterases, Anabaena adenylate cyclases 
and Escherichia coli FhlA) domain (Söding et al., 2005). GAF domains are represented 
in a broad range of signal transduction and sensory pathways (SSDs) and protein 
regulatory systems in all three domains of life (Ho et al., 2000; Martinez, Beavo et al., 
2002; Zoraghi et al., 2004). Proteins containing GAF domains typically bind small 
molecules to exert regulatory functions and thus, GAF domains belong to the 
widespread small-molecule-binding domains (SMBD) (Anantharaman, 2001). Adenylyl 
and guanylyl cyclases i.e. catalyse cyclic nucleotid synthesis and PDEs 
(phosphodiesterases) hydrolyse cGMP (Aravind and Ponting, 1997) or offer a dual 
specificity for cAMP and cGMP (Zhang et al., 2004). Others bind signal molecules like N-
(3-oxo-octanoyl)-L-homoserine lactone as it was observed for TraR (Vannini et al., 2002) 
or show ligand binding specificity towards GTP and the branched-chain amino acids 
(BCAA) isoleucine and valine as discovered for the GAF domain of CodY of B. subtilis 
(Handke et al., 2008; Levdikov et al., 2006). Some GAF domains do not bind any ligand 
and may have purely a structural function through dimerisation (Ho et al., 2000; 
Martinez, Wu et al., 2002). GAF domains show a compact α/β fold with a core sheet of 
typically five or six anti-parallel β-strands which is flanked by α-helices on one side and 
by the ligand binding pocket on the other side. This characteristic GAF domain setup 
can vary with the number of β-sheets and flanking α-helices throughout all GAF 
domains. 
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2.5 Scope of Work 
 
 
Endospore formation in Gram-positive bacteria is a precisely controlled cell 
differentiation process. SpoVT is a key regulator in the late forespore development 
during endospore formation in Bacillus subtilis. 
The transcription factor SpoVT was predicted to integrate two different types of domains: 
a swapped-hairpin β-barrel which presents a new structural DBD-motif of transcription 
factors and a GAF domain. GAF domains mostly are SSDs or act as multimerisation 
modules but its association to a swapped-hairpin β-barrel is novel. The designated GAF 
domain of SpoVT is essential for the DNA-binding specificity of the transcription factor 
but the mode of regulating the activity of SpoVT is not understood. 
 
The goal of this work is to solve the molecular structure of B. subtilis SpoVT by X-ray 
crystallography in order to confirm the predicted architecture of the transcription factor. 
Furthermore, structural and biochemical investigations should deliver insights into the 
functionality of SpoVT and give answers to following questions: 
 
• Is the DBD of SpoVT highly similar to AbrB in structure and probably in DNA-binding 
properties? 
• Does SpoVT form an oligomer since AbrB-like transcription factors are known to 
exert their regulatory functions in a tetrameric state? 
• What is the role of the SpoVT GAF domain? 
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3. RESULTS 
 
 
3.1 Overexpression and Purification of B. subtilis SpoVT 
 
 
3.1.1 SpoVT Full-length 
 
Protein overexpression of SpoVT full-length (SpoVTFL, residues 1-178, Fig. 9a), was 
accomplished in E. coli as described in 6.1.2.1 and 6.2.1. The His6-tagged protein was 
purified by immobilised metal affinity chromatography (IMAC) (see 6.2.2 and 6.3.1.1) 
(Fig. 9b). Elution fractions containing the SpoVTFL protein of 20.6 kDa molecular weight 
(Fig. 9b) were pooled and dialysed against MOPS (3-morpholinopropane-1-sulfonic 
acid) buffer (see 5.3.2 and 6.2.10). Increased purity for 3D-crystallisation trials and rabbit 
immunisation for antibody production was obtained by gel filtration chromatography 
(see 6.3.1.2) (Fig. 9c). 
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. Purification of His6-tagged SpoVTFL. (a) Schematic illustration of the N-terminally His6-tagged SpoVTFL 
dines (H) and residues at the N- and C-terminus indicated. (b, c) SDS-PAGE analyses of the (b) initial 
on step by IMAC and (c) second purification step by gel filtration chromatography. Shown are samples 
i cultures 1 and 2 before induction (b. i.) and after 4 h expression (4 h), cell lysate (CL), load (L), flow 
(FT), wash (W), elution fractions (15, 17, 21, 24, 27; 18–20), and pooled fractions (Pool 18-20) together 
olecular weight marker (M). M proteins are labelled with corresponding masses in kDa and SpoVTFL 
0.6 kDa) is specified. 
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3.1.2 C-terminal Domain of SpoVT 
 
The C-terminal domain of SpoVT (SpoVTCT, residues 56-178, Fig. 10a), was produced 
and isolated similar as described for SpoVTFL (see 3.1.1) (Fig. 10b). 
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Figure 10. Purified His6-tagged SpoVTCT. (a) Schematic illustration of the N-terminally His6-tagged SpoVTCT with 
histidines (H) and residues at the N- and C-terminus indicated. (b) SDS-PAGE analysis of purified SpoVTCT. 
Molecular weight marker (M with masses of proteins in kDa) and SpoVTCT protein (14.4 kDa) are specified. 
 
 
The seleno-methionine (Se-Met) derivate of SpoVTCT for structure solution by X-ray 
crystallography methods was produced and purified by Dr. Sergej Djuranovic, MPI of 
Developmental Biology, Tübingen* (Djuranovic, 2007). 
 
 
 
3.2 Biochemical Analysis of B. subtilis SpoVT 
 
3.2.1 Secondary Structure and Thermal Stability 
 
The SpoVTFL and SpoVTCT proteins overexpressed in E. coli were both properly folded, as 
judged by circular dichroism (CD) spectroscopy (see 6.4.2) (Fig. 11). The shape of the 
curve obtained from SpoVTCT (Fig. 11, green curve) indicates a protein with a 
significantly higher content of α-helical structure elements than the SpoVTFL protein 
(Fig. 11, blue curve). 
 
                                                 
* Present adress: Howard Hughes Medical Institute, Department of Molecular Biology and Genetics, 
Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA 
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Figure 11. CD Spectroscopy of SpoVTFL and SpoVTCT. CD spectra of SpoVTFL and SpoVTCT protein solutions in blue 
and green lines, respectively. 
 
 
 
Estimations of secondary structure content for SpoVTFL resulted in 17% α-helices and 
31% β-sheets and for SpoVTCT in contents of 25% α-helices and 25% β-sheets. The 
estimations for all secondary structure elements are listed in Table 1. 
 
 
Secondary Structure SpoVTFL SpoVTCT
α-helix 17.2% 24.7% 
Anti-parallel β-sheet 24.7% 18.5% 
Parallel β-sheet 6.1% 6.2% 
β-turn 16.5% 15.1% 
Random Coil 33.1% 31.2% 
Total Sum 97.6% 95.7% 
 
Table 1. Secondary Structure Contents of SpoVTFL and SpoVTCT. Estimated secondary structure contents of 
SpoVTFL and SpoVTCT based on CD spectroscopy data (see Fig. 11) within a wavelength range of 200 nm to 
260 nm. 
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The temperature dependent conformational stability of the proteins in solution was 
studied by thermal denaturing experiments recorded via CD spectroscopy methods 
(see 6.4.2). Sigmoid melting curves were determined for both proteins, indicating a 
single-step transition in each case (Fig. 12). The midpoint transition temperature for 
SpoVTFL was 323 K and 314 K for SpoVTCT (Fig. 12), showing a reduced stability of SpoVTCT 
against thermal denaturation compared to the full-length protein. Obviously, auxiliary 
interactions, which are dependent on the presence of the N-terminal domain, stabilise 
SpoVTFL. The denaturations were not reversible as the proteins precipitated during 
heating (Fig. 12). 
 
 
 
Tm = 314 K Tm = 323 K
 
 
Figure 12. Thermal Denaturing of SpoVTFL and SpoVTCT. Melting curves of SpoVTFL (blue) and SpoVTCT (green) 
determined by CD spectroscopy. Midpoint transition temperatures (Tm) are indicated in each case. 
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3.2.2 Oligomeric Form 
 
 
3.2.2.1 Covalent Linkage 
 
Chemical crosslinking (see 6.2.13) is used to determine oligomeric forms of a protein via 
SDS-PAGE analysis (see 6.2.6). The crosslink products of the reaction between glutar-
aldehyde and SpoVTFL or SpoVTCT are shown in Figure 13. 
 
 
 
- GA + GA + GA- GAM
SpoVTFL SpoVTCT
20.6 kDa
14.4 kDa
200
150
120
100
85
70
60
50
40
30
25
20
15
dimer
tetramer
dimer
tetramer
20
25
30
40
50
15
60
70
85
100
120
150
200
heptamer
octaamer
dodecamer
hexamer
octamer
 
 
Figure 13. Crosslinking of SpoVTFL and SpoVTCT. SDS-PAGE analysis of chemically crosslinked SpoVTFL (left) and 
SpoVTCT (right) with 0.025% glutaraldehyde (+GA). Protein samples without glutaraldehyde (-GA) are added in 
each case with monomeric molecular mass of proteins indicated (kDa). Respective oligomeric states of crosslink 
products are specified. Proteins of molecular weight marker (M) are highlighted by their mass (kDa). 
 
 
SpoVTFL showed in crosslinking experiments several oligomeric forms which appeared in 
approximately similar amounts (Fig. 13). Dimers (~ 40 kDa) and tetramers (~ 80 kDa) 
were formed in addition to oligomers of high molecular weights which were defined as 
heptamers (140 kDa), octamers (160 kDa), and dodecamers (220 kDa). In contrast, 
SpoVTCT mainly associated into dimers (30 kDa) (Fig. 13). Low amounts of tetramers 
(60 kDa) and very low amounts of hexamers (90 kDa) and octamers (120 kDa) were 
detected, additionally. 
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3.2.2.2 Native State 
 
In gel filtration experiments, both proteins eluted as single peaks (Fig. 14) indicating 
monodisperse protein solutions. Analysis of the peak fractions by SDS-PAGE confirmed 
the monomeric molecular mass of SpoVTFL (20.6 kDa, Fig. 14) and SpoVTCT (14.4 kDa, 
Fig. 14). Using a Superdex 75 column (see 6.3.1.2), SpoVTFL eluted at a retention time of 
28 min corresponding to a tetrameric protein complex of ~ 80 kDa (Fig. 14). SpoVTCT 
elution occurred at a retention time of 37 min representing a dimeric protein domain of 
~ 30 kDa (Fig. 14). 
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Figure 14. Gel Filtration Chromatography of SpoVTFL and SpoVTCT. Gel filtration chromatogram of SpoVTFL and 
SpoVTCT using a Superdex 75 column with elution profiles in blue and green, respectively. Column calibration, 
depicted as a red curve, was performed with albumine (A, 67 kDa), ovalbumine (OA, 43 kDa), and chymo-
trypsinogen A (CT A, 25 kDa). SDS-PAGE analysis of peak fractions is illustrated by the gel below. Proteins of 
molecular weight marker (M) are specified. 
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3.2.3 Immunological Detection of Native SpoVT 
 
 
3.2.3.1 Generation of Polyclonal Rabbit Anti-SpoVT Antibodies 
 
Polyclonal anti-SpoVT antibodies were generated by rabbit immunisation using two-step 
purified His6-tagged SpoVTFL (see 6.2.2 and 6.3.1.2) overexpressed in E. coli at a 
concentration of 2.31 mg*ml-1 in 1x PBS buffer (see 5.3.2). Antibody production was 
boosted by three consecutive rabbit immunisations (see 6.2.3). Finally, ~ 35 ml of rabbit 
blood were obtained which left ~ 20 ml blood serum containing the polyclonal anti-
SpoVT antibodies. A 1:5000 dilution of the blood serum detected by far < 20 ng of the 
antigen in an initial immuno (western) blotting experiment (see 6.2.9), judging a 
sufficient sensitivity of the anti-SpoVT antibodies against the antigen (Fig. 15). 
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Figure 15. Sensitivity of Polyclonal Rabbit Anti-SpoVT Antibodies. SDS-PAGE analysis (left) and developed X-ray 
film of equivalent immuno blot (right) of an initial test of rabbit blood serum (1:5000 dilution) containing 
polyclonal anti-SpoVT antibodies. Applied proteins (His6-tagged SpoVTFL, 20.6 kDa; His6-tagged SpoVTCT, 14.4 kDa; 
and GroEL, 57.2 kDa) in different amounts (40, 30, 20, and 15 ng) and molecular weight marker (M, kDa) are 
specified. 
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3.2.3.2 Purification of Polyclonal Anti-SpoVT Antibodies 
 
The polyclonal anti-SpoVT antibodies were purified from rabbit blood serum by affinity 
chromatography (see 6.2.4) (Fig. 16). The antigen was coupled to an affinity medium as 
bait which specifically immobilises the antibodies from the serum. Elution of the antigen-
antibody complex was performed by a pH-shift. 
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Figure 16. Purification of Anti-SpoVT Antibodies. SDS-PAGE analysis of purification of anti-SpoVT antibodies via 
affinity chromatography showing samples of the antigen (SpoVTFL), SpoVTFL coupled to affinity beads (SB), flow 
through (SFT) and wash (SW) of coupling procedure, blood serum (load, L), serum flow through (FT), washing steps 
(W1-W3), and elution fractions (1-5). Molecular weight marker (M) and proteins of the eluates are specified and 
labelled with respective masses in kDa. 
 
 
Eluates 2-5 (Fig. 16) were pooled and extensively dialysed against 1x PBS buffer (see 
6.2.10). During the dialysis procedure, proteins precipitated and efforts in solubilisation 
and refolding the denatured protein agglomerates were not successful. Changing of 
dialysis conditions regarding temperature and application of glycerol for protein 
protection did not improve the stability of the proteins. Purification of 1 ml rabbit blood 
serum yielded ~ 1.1 mg anti-SpoVT antibodies. 
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3.2.3.3 Synchronisation of B. subtilis Cells and Induction of Sporulation 
 
For detection of homologously expressed native SpoVT, B. subtilis cells were 
synchronised and sporulation was induced by exhaustion in DSM medium as written in 
6.1.2.3 – 6.1.2.5. Growth curve determination of B. subtilis cells in liquid culture is 
described in 6.1.2.7 (Fig. 17). 
The developmental expression profile of SpoVT in B. subtilis was determined by Bagyan 
et al. (Bagyan et al., 1996). According to this, SpoVT expression starts 2.5 h (t = 150, 
blue figure, Fig. 17) after initiation of sporulation (t = 0, blue figure, Fig. 17) and 
increases continuously within the following 3.5 h. 2.5 h after entering the stationary 
phase (T2.5, green arrow, Fig. 17), SpoVT attains its highest expression level (Bagyan et al., 
1996). 
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Figure 17. Growth Curve of Synchronised Sporulating B. subtilis Cell Culture. Growth curve of synchronised 
B. subtilis cell culture with arrow in orange indicating harvest of cells from LB medium. Figures in blue count for 
cultivation in DSM medium. Green arrow points at term of presumed highest SpoVT expression level (T2.5). 
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Endospore formation was verified by light microscopy (LM) inspection of cells after spore 
staining (see 6.1.2.8) in comparison to B. subtilis cells which were not incited to sporulate 
(LB medium) (see 6.1.2.3) (Fig. 18). 
 
 
 
a b
 
 
Figure 18. Black-and-white Shots of LM-micrographs of B. subtilis Cells. (a) Vegetative life-form of B. subtilis. (b) 
Terminal endospores in B. subtilis cells and distention of mother cells are indicated with arrows. Stained spores 
appear as dark cell compartments. 
 
 
 
 
3.2.3.4 Immuno Blotting 
 
Samples of sporulating B. subtilis cells, taken from liquid culture at different stages of 
development (see Fig. 17, blue figures), were treated as described in 6.3.6. Solutions 
containing solubilised spore proteins were analysed by immuno (western) blotting using 
polyclonal rabbit anti-SpoVT antibodies (see 3.2.3.2) as the primary antibody. As the 
secondary antibody, goat anti-rabbit IgG linked to horseradish peroxidase was applied 
(see 6.2.8 and 6.2.9). Figure 19 shows an image of an X-ray film which was exposed to 
the chemoluminescent agent treated membrane of such an immuno blotting 
experiment. 
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Figure 19. Western Blot Analysis of Spore Extracts. Developed X-ray film of western blot experiment analysing 
spore extracts drawn from B. subtilis cell culture at denoted time points (30 – 390 min and over night (o. n.)) as 
described in Figure 17 using specific anti-SpoVT antibodies. Purified SpoVTFL (~ 100 ng) is added as positive 
contol. Proteins of molecular weight marker (M) are specified (kDa). 
 
 
Detection of SpoVT in B. subtilis spore extracts using anti-SpoVT antibodies failed (Fig. 19). 
A protein of low molecular weight (below 10 kDa) was recognised by the anti-SpoVT 
antibodies in each sample applied to western blot experiments (30 min - o. n., Fig. 19). 
In samples taken from the sporulating culture till its entry into the stationary phase 
(t = 150, see Fig. 17), a protein of about 38 kDa and during the stationary phase 
(t = 150 - 270), a protein of a slightly lower molecular mass was recorded by the anti-
SpoVT antibodies (Fig. 19). It is assumed that this might be due to unspecific 
interactions. Variations in the experimental setup concerning the amount of applied 
spore proteins and/or anti-SpoVT antibodies had no influence. 
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3.3 3D-Crystallisation and Structural Analysis of B. subtilis SpoVT 
 
 
 
3.3.1 X-ray Crystallography 
 
3D-crystallisation experiments were carried out by Dr. Sergej Djuranovic, MPI of 
Developmental Biology, Tübingen* as described in 6.4.1.1. The protein solutions of 
SpoVTFL, SpoVTCT, and the Se-Met derivate of SpoVTCT have been adjusted to final 
concentrations of 10 and 20 mg*ml-1 (see 6.2.11). 
The SpoVTFL crystals were of a robust cubic morphology (Fig. 20a) grown with addition of 
1 M NaCl, 100 mM cacodylate pH 6.5, 30% (v/v) PEG (polyethyleneglycol) 600, and 
10% (v/v) glycerol (Emerald BioSystems, Cryo screen II, condition 6). Crystals of SpoVTCT 
can be described as clusters of thin and tapered plates (Fig. 20b) and emerged in 
200 mM NaCl, 100 mM HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) 
pH 7.5, and 25% (w/v) PEG 3350 (Hampton Research, Index screen, condition 72) while 
its Se-Met derivate produced fragile tubular crystals in 200 mM MgCl2, 100 mM HEPES 
pH 7.5, and 25% (w/v) PEG 3350 (Hampton Research, Index screen, condition 84). The 
initial crystallisation condition of the Se-Met protein was optimised by application of 
additives (Hampton Research, Additive screen, see 6.4.1.1). Fast-growing Se-Met 
SpoVTCT crystals appeared in clusters of tubes, needles, and/or plates of variable size 
(Fig. 20c). After an incubation period of 3.5 months, in conditions including 3% (w/v) 
dextran sulfate Se-Met SpoVTCT crystals of a different morpholgy re-emerged. These slow-
growing SpoVTCT Se-Met crystals formed single crystals of a hexagonal cigar-like shape in 
different dimensions (Fig. 20d). 
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25% (w/v) PEG 3350, 3% (w/v) dextran sulfate  
c d 
 
Figure 20. Protein Crystals of SpoVT. Light microscope images of protein crystals of (a) SpoVTFL, 
0.5 x 0.15 x 0.15 mm, (b) SpoVTCT, 0.5-0.1 x 0.07-0.03 x 0.02-0.01 mm, (c) Se-Met SpoVTCT fast-growing, 
0.2 x 0.03 x 0.03 mm, and (d) SeMet SpoVTCT slow-growing, 0.4-0.1 x 0.1-0.03 x 0.1-0.03 mm. Crystallisation 
conditons and protein concentrations are added in each case. 
 
 
Single protein crystals were mounted in cryo loops (see 6.4.1.2), frozen, and exposed to 
X-ray radiation at the SLS beamline X10SA PXII at the PSI in Villigen, Switzerland. X-ray 
diffraction images were recorded on a mar225 CCD detector (Fig. 21). Data for SpoVTFL 
were aquired at a wavelength of 0.978 Å, for SpoVTCT and its Se-Met derivate at 0.979 Å 
(see 6.4.1.2). 
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 a b 
SpoVTFL crystal, 2.6 Å slow-growing Se-Met SpoVTCT crystal, 2.1 Å  
 
 
Figure 21. Diffraction Images of SpoVT Crystals. Diffraction images of protein crystals of (a) SpoVTFL and (b) slow-
growing Se-Met SpoVTCT with respective resolutions. 
 
 
The native crystals diffracted to resolutions of 2.6 Å for SpoVTFL (Fig. 21a) and 1.5 Å for 
SpoVTCT (data not shown). The fast-growing SpoVTCT Se-Met crystals diffracted poorly to 
only 3.5 Å with a diffraction pattern showing multiple lattices caused by the cluster 
formation of the crystals (data not shown). For the slow-growing crystals of the Se-Met 
derivate, a resolution of 2.1 Å was obtained (Fig. 21b) and a highly redundant SAD 
(single anomalous dispersion) dataset at the selenium absorption edge was collected 
(see 6.4.1.2). 
SpoVT crystals occurred in the tetragonal crystal form and space group P43212. The unit 
cell of the Se-Met derivate of SpoVTCT showed dimensions of a = b = 64.6 and 
c = 78.6 Å, α = β = γ = 90°. Rmerge and I/σ(I) were defined to 8.5 and 14.3 for resolution 
range 20.0-2.06 Å, respectively. Native SpoVTCT crystallised in a slightly smaller unit cell 
with dimensions of a = b = 63.9 and c = 77.3 Å. For resolution range 20.0-1.50 Å, an 
Rmerge of 6.3 and I/σ(I) of 14.8 was determined. The unit cell of SpoVTFL was considerably 
bigger and of dimensions a = b = 94.5 and c = 110.8 Å, α = β = γ = 90°. Rmerge and 
I/σ(I) of 10.5 and 13.9, respectively were specified for resolution range 20.0-2.60 Å. Data 
collection statistics are shown in more detail in Table 2. 
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Data Collection Se-Met SpoVTCT Native SpoVTCT Native SpoVTFL
Residues 56-178 56-178 1-178 
Wavelength (Å) 0.979 0.979 0.978 
Resolution Range (Å) 
(outer shell) 
20.00 - 2.06 
(2.19 - 2.06) 
20.00 - 1.50 
(1.71 - 1.50) 
20.00-2.60 
(2.80 – 2.60) 
Crystal form tetragonal tetragonal tetragonal 
Space group P43212 P43212 P43212 
Cell dimensions (Å) a = b = 64.6, c = 
78.6 
a = b = 63.9, c = 
77.3 
a = b = 94.5, c = 
110.8 
Unique reflections 
Observed reflections 
19148 (2866) 
220814 (31146) 
25488 (3818) 
182057 (28670) 
18815 (2783) 
177074 (20904) 
Redundancy 11.5 (10.9) 7.1 (7.5) 9.4 (7.5) 
Completeness (%) 97.8 (91.3) 99.0 (100) 99.4 (90.4) 
Rmerge (%) 8.5 (26.9) 6.3 (25.4) 10.5 (46.2) 
I/σ(I) 14.3 (4.7) 14.8 (4.5) 13.9 (3.0) 
 
Table 2. X-ray Data Collection Statistics. Collected X-ray data of protein crystals of SpoVTCT Se-Met derivate, 
native SpoVTCT, and native SpoVTFL. 
 
 
3.3.2 Phasing and Density Fitting 
 
X-ray data analysis of Se-Met SpoVTCT determined six selenium sites which were located 
using Patterson methods (Patterson, 1934). The experimental phases were determined 
at 2.1 Å (see 6.4.1.3) (Terwilliger, 2000; Terwilliger and Berendzen, 1999). The calculated 
Matthew coefficient of 2.9 and a solvent content of 58.1% (Matthews, 1968) suggested 
that the asymmetric unit of SpoVTCT is consisting of one molecule. 
The structure of SpoVTFL was solved by molecular replacement (see 6.4.1.3) using the 
refined model of SpoVTCT as search model (Vagin and Teplyakov, 1997). Attempts to 
complete the SpoVTFL structure by molecular replacement using one chain of the NMR-
structure of the N-terminal part of the homologous AbrB protein (PDB entry 1YFB) failed. 
Solvent flattening techniques were applied to improve the quality of the phases and an 
electron density was achieved by reducing the model bias via prime-and-switch 
phasing (RESOLVE, (Terwilliger, 2003)). The SpoVTFL structure was completed by density 
fitting the N-terminal part of AbrB, AbrBNT (PDB entry 1YFB), into the improved and 
averaged map (see 6.4.1.4). Two SpoVTFL monomers were found in the asymmetric unit 
and a Matthew coefficient of 3.2 and solvent content of 61.1% was determined 
(Matthews, 1968). 
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3.3.3 Model Building and Structural Refinement 
 
With the data of the Se-Met derivate of SpoVTCT, RESOLVE (Terwilliger, 2003) built a partial 
model of SpoVTCT automatically (Fig. 22). Missing parts of the protein were built manually 
by placing appropriate amino acids into the electron density map. The model was 
refined by iterative cycles of manual model rebuilding (Emsley and Cowtan, 2004) and 
refinement (Murshudov et al., 1997) (see 6.4.1.4) and later refined against the native 
data set of SpoVTCT at 1.5 Å. The improved quality of the electron density gained by the 
refinement processes is illustrated in Figure 22. 138 solvent waters were added 
automatically (Perrakis et al., 2001) and the refined model of SpoVTCT showed an 
Rcryst/Rfree ratio of 19.7%/22.6% and a good stereochemistry (see Table 3). The SpoVTCT 
model consisted of 120 consecutive amino acids. The N-terminal His6-tag and the 
following amino acid as well as the last two residues of the protein domain were missing 
due to a low quality of the electron density at the N- and C-terminus of the structure. 
 
 
 
 
 
Figure 22. Electron Density of SpoVTCT Data. Initial (left) and improved (right) electron density of SpoVTCT data 
including initial fragmentary and completed SpoVTCT model, respectively. Electron density map is shown in blue 
at 1.5 σ and chain of SpoVTCT model is coloured by atoms. 
 
 
 
The initial SpoVTFL model was constituted from two protein domains; SpoVTCT, which was 
solved as described above, and AbrBNT, deposited at the PDB under accession number 
1YFB. Residues different between the N-terminus of SpoVT (SpoVTNT, amino acids 1-48) 
and AbrBNT were exchanged and missing domain connecting residues were placed 
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manually. The model was refined by several cycles of manual model rebuilding and 
automatically structural refinement with twin lattice symmetry (TLS) and NCS restraints. For 
TLS refinement, the two different domains of SpoVTFL were defined as two separate rigid 
bodies (amino acids 2-51 and 56-177). The TLS parameters were refined for each 
molecule of the asymmetric unit. NCS restraints were placed between these two 
monomers. NCS-related atoms were defined as two regions spanning the amino acids 
10-49 and 57-175, leaving the domain connecting linker unrestrained. The current 
model of SpoVTFL consists of four chains with residues 2–176 for chain A and C (N-
terminal His6-tag, initial methionine, and two amino acids at the C-terminus absent) and 
residues 4-176 for chain B and D (N-terminal His6-tag, following three amino acids, and 
two residues at the C-terminus absent) with proper stereochemistry and an Rcryst/Rfree 
ratio of 23.4%/28.6%. 28 water molecules were found. All refinement data statistics are 
shown in Table 3. 
 
 
 
Refinement Native SpoVTCT Native SpoVTFL
Residues 56-178 1-178 
Resolution range (Å) 20.00-1.50 20.00-2.60 
Unique reflections 24816 15100 
Rcryst/Rfree (%) 19.7/22.6 23.4/28.6 
No. of protein atoms 1038 2668 
No. of waters 138 28 
r.m.s.d. of bond length (Å) 0.01 0.02 
r.m.s.d. of bond angles (°) 1.3 2.2 
Average B factor (Å2) 55.7 64.8 
Ramachandran plot statistics, 
residues 
  
in most favoured regions (%) 92.3 84.2 
in add. allowed regions (%) 5.8 13.5 
in gen. allowed regions (%) 1.0 1.6 
in disallowed regions (%) 1.0 0.6 
 
Table 3. X-ray Data Refinement Statistics. Refinement of X-ray data of SpoVTCT and SpoVTFL. 
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3.4 Structure of B. subtilis SpoVT 
 
 
3.4.1 Crystal Packing 
 
 
SpoVT proteins crystallised in a primitive tetragonal Bravais lattice (Pt) with space group 
P43212. The space group defines a 4-fold axis with two perpendicular diagonal 2-fold 
axes (point group 422). The 2-fold screw axis (21) defines a rotation of 180° and ½ 
translation (Fig. 23a1 and b1) and the 4-fold screw axis (43) describes a rotation of 90° 
and translation of ¾ of the unit cell (Fig. 23a2 and b2). 
 
 
90 °
90 °a
c
b
a
b
c
a
b
c
a
c
b
 
a1 a2 
b1 b2 
 
Figure 23. Crystal Packing of SpoVT Crystals. Crystal packing of (a) SpoVTFL and (b) SpoVTCT in space group 
P43212 with homotetramers and homodimers in different colours, respectively. (a1) and (b1) show view along the 
2-fold screw axis and (a2) and (b2) along the 4-fold screw axis. 
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3.4.2 Overall Fold of Tetrameric Complex 
 
The structure of SpoVTFL determined by X-ray crystallography revealed that native SpoVTFL 
forms a complex of four monomers (chain A, B, C, and D, Fig. 24a). The SpoVTFL 
tetramer is an elongated protein complex with dimensions of approximately 
10 x 5 x 5 nm (Fig. 24) and of a convex shape (Fig. 24b). The tetrameric complex forms 
a spiral with an overall twist of about 50° which can be observed in the stereogram of 
the SpoVTFL model in Figure 25. 
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Figure 24. Overall Fold of SpoVTFL Tetramer. Transparent surface representation with underlying Cα traces 
showing secondary structure elements of the SpoVTFL tetramer. Tetramers are coloured by monomers (chain A in 
yellow, B in green, C in red, and D in blue). (a) Topview with monomers, dimensions, and N- and C-termini of 
monomers B and D indicated. (b) Presentation similar to (a) with focus onto the convex shape. 
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The SpoVTFL complex is a dimer of dimers. Monomers associate pairwise via their SpoVTNT 
domains and the dimers further assemble through their SpoVTCT domains which extend 
in opposite directions (Fig. 24 and Fig. 25). Thereby, the SpoVTNT domains form a core-
like structure which is surrounded by the SpoVTCT domains. The SpoVTFL tetramer shows an 
overall asymmetry based on an anti-parallel arrangement of asymmetric dimers 
(Fig. 24 and Fig. 25). Thus, in the tetramer, monomer A is the symmetry equivalent to 
monomer C and monomer B to monomer D (Fig. 24a). 
 
 
 
 
 
Figure 25. Stereo Presentation of SpoVTFL Tetramer. Cartoon illustration of the tetrameric SpoVTFL with colour 
code as shown in Figure 24. 
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3.4.3 Asymmetric Tetramer 
 
The asymmetric SpoVTFL dimers are curved with a bend of ~ 80° and the central SpoVTNT 
domains shifted by about 6 Å (Fig. 26a). The asymmetry of the dimer is based on 
different conformations of the monomers (Fig. 26a). In the crystal structure of SpoVTFL, a 
monomer with an elongated overall fold showing an expanded domain connecting 
linker, termed E, and a more compact monomer with a conjoined and structured inter-
connecting linker, termed S, is obvious (Fig. 26a). 
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Figure 26. Asymmetry of SpoVTFL and Structured S Linker. (a) Cartoon presentation of SpoVTFL dimer in colours 
according to calculated B-factors from high (red) to low (blue) values. Domains are indicated and connecting 
linkers are marked by ellipses. Monomers are termed according to the conformation of the linker; E (elongated) 
and S (structured). (b) Electron density of the S linker peptide. S monomer is depicted in yellow in a ribbon 
presentation with domains denoted. Electron density map is shown in blue at 1.2 σ. 
 
 
The residues composing the linker in E have high B-factors and a poor quality of the 
electron density in the central linker region together indicate a substantial flexibility 
(Fig. 26a). The linker in S is more well-defined (Fig. 26b) and contributes to the 
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stabilisation of the SpoVTFL tetramer. Two pairs of salt bridges (Arg40 and Glu54) are 
formed between the opposing S monomers A and C (Fig. 27a). These constrain the 
flexibility of the linker and lead to the formation of an α-helical turn in this region 
(Fig. 26). The resulting rotation of SpoVTNT relative to SpoVTCT arranges the two domains 
that they interact via two salt bridges between residues Arg29 and Asp80, and Arg27 
and Glu103, respectively (data not shown). 
Residues stabilising the S conformation are highly conserved among the SpoVT 
orthologs taken for the alignment in Figure 27b, exept for the amino acid Arg40 
regarding SpoVT from Caldicellulosiruptor saccharolyticus. 
These intra- and intermolecular salt bridges within the SpoVTFL tetramer are supposed to 
support the unusual asymmetry of the entire protein complex. 
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Figure 27. Stabilisation of the Asymmetry of SpoVTFL and Sequence Alignment. (a) Zoom-in depiction to the 
intermolecular interaction of S. Amino acids are presented as sticks with element colour code and labels. 
Interacting monomers are specified with colour code as shown in Figure 25. (b) Alignment of SpoVT orthologs: 
BACSU, B. subtilis; BACLD, B. licheniformis; BACAN, B. anthracis; BACAH, B. thuringiensis; BACCE, B. cereus; 
GEOKA, G. kaustophilus; BACSK, B. clausii; BACHD, B. halodurans; CARHZ, C. hydrogenoformans; MOOTA, 
M. thermoacetica; SYMTH, S. thermophilum; CLOPS, C. perfringens; CLOBE, C. beijerinckii; CLOBO, 
C. botulinum; CLOAB, C. acetobutylicum; THETN, T. tengcongensis; CALSA, C. saccharolyticus; CLOD6, 
C. difficile. Secondary structure elements of B. subtilis SpoVT (Bacsu) are indicated above with β-sheets as yellow 
arrows and α-helices as red tubes. Triangles mark amino acids involved in stabilisation of the asymmetry; blank 
(∆) for intermolecular and filled (▲) for intramolecular interactions in S. Squares (◊) point at amino acids which 
form contacts between SpoVTCT in the SpoVTFL tetramer. Colour-coding is based on ClustalW (Higgins et al., 
1994); (*) invariant, (:) strongly conserved, and (.) semi-conserved amino acids. 
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3.4.4 Two Different Monomers 
 
The two different monomers in the structure of the SpoVTFL tetramer are of substantial 
conformational variability. The SpoVTFL monomers are composed of a structured SpoVTNT 
domain which encompasses the amino acids 1-48 and a compact SpoVTCT domain 
which is built by the residues 56-178. SpoVTNT folds as two pairs of β-hairpins (β1, β2 and 
β3, β4) with an interjacent α-helix (α1) as displayed in Figure 28. The globular SpoVTCT 
consists of four α-helices (α2-α5) and an anti-parallel five-standed β-sheet (β5-β9) 
(Fig. 28b). The amino acids 49-55 form the domain-connecting linker which represents 
the most flexible part of the protein (see Fig. 26a). 
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Figure 28. SpoVTFL Monomers. (a) Ribbon representation of superposed monomers of SpoVTFL; E (blue) and S 
(red). N- and C-termini and secondary structure elements of SpoVTNT are labelled in each monomer. α-helix of 
the linker in S is marked by an ellipse. (b) Topology diagram (Bond, 2003) of SpoVTFL with β-sheets as arrows (red) 
and α-helices as barrels (blue). N- and C-terminus and secondary structure elements are indicated. Domain 
connecting linker is pointed out as a bold line. 
 
 
A superposition of the differing monomers E and S demonstrates the extent of the 
rotation of SpoVTNT relative to SpoVTCT which is enabled by the flexibility of the domain 
connecting linker (Fig. 28a). This rotation of SpoVTNT is responsible for the overall twist of 
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~ 50° observed in the tetrameric complex, stabilised by salt bridges which lock the 
SpoVTFL tetramer in the asymmetric conformation (see 3.4.3). In S, interaction of the 
domains generates an interaction area of 200 Å2 (Krissinel and Henrick, 2007) which 
leads to a more compact overall fold compared to E. The elongated monomer E 
adopts a hook-shaped structure grasping with SpoVTNT the SpoVTNT domain of S, as 
clearly visible in the surface illustration of the tetrameric model presented in Figure 24a 
(monomers B and D). The SpoVTCT domains of the varying monomers are, in contrast to 
their positional variability, almost similar which is reflected by a root mean square 
deviation (r.m.s.d.) of 0.4 Å (122 superimposed Cα atoms) (Claude et al., 2004). The 
largest structural variations exist for the loop which locks the putative ligand binding 
pocket (data not shown). 
 
 
 
 
3.4.5 Multimerisation Modules 
 
Two dimerisation modules organise the quaternary structure of SpoVTFL: SpoVTNT domains 
of two monomers form a tight connection and act in a central close alliance; their 
globular SpoVTCT domains are stretched out in opposite directions and couple two 
dimers in an anti-parallel manner via helical interactions. 
 
 
3.4.5.1 N-terminal Domain 
 
The interleaving of the four β-hairpin elements of two SpoVTNT domains results in a homo-
dimeric eight-stranded anti-parallel β-barrel. The barrel is capped on both ends by two 
opposite and symmetry related helices α1 and α1’ (Fig. 29a). The central βαβ-element 
and the characteristically exposed β1-β2/β1’-β2’ loops (Fig. 29) assign this type of fold 
into the group of swapped-hairpin β-barrels (Coles et al., 2005). The name of this fold 
derives from the characteristic topology as depicted in Figure 29b. 
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Figure 29. Dimer of SpoVTNT. N- and C-termini and secondary structure elements of dimeric SpoVTNT are 
indicated. (a) Overall structure of dimeric SpoVTNT in a cartoon representation in side (left) and top (right) view. 
Monomers are colour-coded. (b) Topology diagram (Bond, 2003) of dimeric SpoVTNT with β-sheets as arrows (red) 
and α-helices as barrels (blue). Monomers are in different colour intensities and characteristic β1-β2/β1’-β2’ loops 
are highlighted as bold lines. 
 
 
The extensive dimerisation interface of 1690 Å2 is stabilised by a large network of 
hydrogen bonds (Krissinel and Henrick, 2007) mediated by residues which are highly 
conserved throughout SpoVT orthologs (see Fig. 27b and Table 4). 
 
No. Chain, Residue, Atom Distance (Å) Chain, Residue, Atom 
1 A, Ile36, N 2.8 B, Ile6, O 
2 A, Leu34, N 2.6 B, Arg8, O 
3 A, Gly31, N 2.8 B, Ile10, O 
4 A, Ile18, N 3.1 B, Gly14, O 
5 A, Val16, N 3.1 B, Val16, O 
6 A, Ile10, N 3.5 B, Asp32, O 
7 A, Arg8, N 3.0 B, Leu34, O 
8 A, Thr4, OG1 2.6 B, Ile36, O 
9 A, Leu46, N 3.0 B, Val44, O 
10 A, Val44, N 2.8 B, Leu46, O 
11 A, Ile6, O 3.0 B, Ile36, N 
12 A, Arg8, O 2.6 B, Leu34, N 
13 A, Ile10, O 2.6 B, Gly31, N 
14 A, Gly14, O 3.3 B, Ile18, N 
15 A, Val16, O 3.0 B, Val16, N 
16 A, Asp32, O 3.7 B, Ile10, N 
17 A, Leu34, O 2.9 B, Arg8, N 
18 A, Ile36, O 3.1 B, Thr4, OG1 
19 A, Val44, O 2.9 B, Leu46, N 
20 A, Leu46, O 2.9 B, Val44, N 
 
Table 4. Details of the SpoVTNT β-barrel Interface. Contacts (No. 1-20) mediating dimerisation of SpoVTNT with 
corresponding distances (Krissinel and Henrick, 2007). Interactions conserved between β-barrels of SpoVTNT and 
AbrBNT are coloured in green. 
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The swapped-hairpin β-barrel of SpoVT is characterised by 24 highly conserved and 
positively charged amino acids taken for the sequence alignment in Figure 27b. Eight 
arginines (Arg8, Arg9, Arg15, Arg23, Arg24, Arg27, Arg29, and Arg40) and four lysines 
(Lys2, Lys20, Lys47, and Lys48) of each monomer contribute to an unusually high 
charge density of the protein domain. The surface representation in Figure 30 illustrates 
the charge property of SpoVTNT with a net charge of plus three. Particularly the α1-
helices, which are part of a girdle of positive charges surrounding the protruding β1-β2 
and β1’/β2’ loops, define patches of an extraordinarily high positive charge distribution 
(Fig. 30). The arginines are exclusively oriented to one face of the domain (Fig. 30), 
exept for Arg40 which was discovered to be important in tetramer stabilisation (see 
3.4.3). 
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Figure 30. Surface Charge Potential of Dimeric SpoVTNT. SpoVTNT in surface representation illustrating its surface 
charge potentials. Domain orientations are similar to Figure 29a and arginines are marked. Charge potentials 
are coloured in blue and red for basicity and acidity, respectively (values coloured from -10 (red) to 10 (blue) 
kT/e). 
 
 
 
3.4.5.2 C-terminal Domain 
 
As observed by X-ray crystallography and gel filtration chromatography, SpoVTCT forms a 
homodimer which adopts a highly compact overall shape (Fig. 31). The SpoVTCT dimer 
has a strong net negative charge (Fig. 31a), quite contrary to the positively charged 
SpoVTNT domain (see Fig. 30). Intensive negatively charged patches are located around 
the connecting region (Fig. 31a). 
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Figure 31. Dimer of SpoVTCT. (a) SpoVTCT dimer in transparent surface representation demonstrating its surface 
charge potentials. Underlying Cα trace highlights secondary structure elements. Charge potentials are coloured 
in blue and red for basicity and acidity, respectively (values coloured from -10 (red) to 10 (blue) kT/e). (b) 
Cartoon representation of the overall fold of dimeric SpoVTCT coloured by monomers. C-termini are indicated. 
 
 
In the SpoVTCT dimer, the interface is an anti-parallel four-helical coiled coil to which 
each monomer contributes two helices (Fig. 31b). Thereby, the N-terminal helix of one 
monomer contacts the C-terminal helix of the second monomer and vice versa. The 
interaction area of 610 Å2 (Krissinel and Henrick, 2007) is quite small which is based on 
the peculiar twist of the monomers against each other (Fig. 31b and 32a). A pair of 
Arg174 and Asp68 forms two intermolecular salt bridges between two SpoVTCT 
monomers and Lys163 and Ser69 support interaction by hydrogen bond formation 
between the oxygen of the main chain of the lysine and the OH-group of serine and the 
NH-group of the side chain of lysine and the oxygen of the main chain of serine. 
Additionally, Tyr62 of each monomer contributes a hydrogen bond between the OH-
groups (Fig. 32b). The amino acids Tyr62 and Lys163 are invariant and Arg174 is strongly 
conserved among the SpoVT orthologs according to the sequence alignment shown in 
Figure 27b. 
The overall fold and the dimerisation mode observed in the structure of SpoVTCT in 
isolation are essentially identical to that in the full-length protein (compare Fig. 25) 
(r.m.s.d. between 120 Cα atoms of 0.5 Å, data not shown) (Claude et al., 2004). 
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Figure 32. SpoVTCT Dimer Interface. (a) Illustration of the twist (45°) of the SpoVTCT dimer. Monomers are coloured 
as shown in Figure 31b. (b). Electron density of interacting tyrosines (Tyr62) at the SpoVTCT dimer interface. 
Residues are presented as sticks and electron density map is depicted in blue at 1.5 σ. Subunits in ribbon 
presentation are with colour code similar to (a). 
 
 
 
3.4.6 Novel Domain Architecture 
 
3.4.6.1 Swapped-hairpin β-barrel 
 
The swapped-hairpin β-barrel classifies SpoVT as a member of the AbrB-like transcription 
factor superfamily (Coles et al., 2005). SpoVTNT closely resembles the structure of AbrBNT 
(PDB entry 1YSF) (Fig. 33a) which is the core structure element of the superfamily. The 
homology between SpoVTNT and AbrBNT is reflected by an r.m.s.d. of 1.0 Å between 48 
aligned Cα atoms (Claude et al., 2004). A sequence alignment (Higgins et al., 1994) 
reveals 68% identity and arginines essential for the DNA-binding activity of AbrBNT 
(Strauch et al., 2005) are conserved between both proteins (Fig. 33b). The arginines 
which are conserved in sequence and structure (Arg8, Arg15, Arg23, and Arg24) are 
exposed similarly to one face of the barrel (Fig. 33a) presumably to generate a domain 
moiety prone to bind selected segments of negatively charged DNA. Non-homologous 
residues between the closely related domains are present solely in the region around 
the linker which connects the α-helix to the β3-sheet. Additionally, the amino acid Arg40 
which seems to be important in SpoVTFL is not present in AbrB (Fig. 33). 
Structural similarities to other members of the AbrB-like superfamily are noted for Abh 
(PDB entry 2FY9) which is a paralogue of AbrB in B. subtilis (Bobay et al., 2006) and the 
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E. coli DNA-binding proteins MazE (Loris et al., 2003) and MraZ (PDB entry 1N0G) (Chen 
et al., 2004). The N-terminal part of MazE (MazENT) forms an intertwined homodimeric β-
barrel (PDB entry 1MVF (Loris et al., 2003)) quite similar to the swapped-hairpin β-barrel of 
AbrBNT and SpoVTNT. A Z-score of 4.7 (Holm and Sander, 1993) and an r.m.s.d. of 1.1 Å 
between 41 aligned Cα atoms (Claude et al., 2004) was observed by a superposition of 
SpoVTNT and MazENT. The arginines of the MazENT dimer are crucial in specific DNA-
binding (Loris et al., 2003) and perfectly positioned for attaching to DNA (see 4.2, 
Fig. 41). 
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Figure 33. Swapped-hairpin β-barrels of SpoVTNT and AbrBNT. (a) Side (left) and top (right) view of superposed 
swapped-hairpin β-barrels of SpoVTNT (red) and AbrBNT (PDB entry 1YSF) (blue) with arginines shown as sticks. 
Arginines of SpoVTNT are labelled with yellow colour indicating conserved arginines according to sequence 
alignment in (b). (b) Sequence alignment of SpoVTNT of B. subtilis (1-51, SNT_BACSU) and AbrBNT of B. subtilis (1-53, 
ANT_BACSU). Filled triangles (▲) assign conserved arginines responsible for AbrB mediated DNA-binding. Colour-
coding is based on ClustalW (Higgins et al., 1994); (*) invariant, (:) strongly conserved, and (.) semi-conserved 
amino acids. 
 
 
All homologs presented have no particular protein domain at their C-terminus. Exept for 
the monomeric MraZ, simply elongated and unfolded polypeptide chains of 30-40 
amino acids are assumed or known to display the C-terminal part. On the contrary, 
SpoVTFL defines a compact and globular SpoVTCT domain which is unique throughout 
AbrB-like transcirption factors. This represents a novel domain architecture in transcription 
factors. 
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3.4.6.2 GAF Domain 
 
SpoVTCT was predicted to belong to the large GAF domain family clade according to 
sequence and structure comparison methods (Coles et al., 2005). 
Structure determination of SpoVTCT confirmed that the domain adopts a GAF fold 
(Fig. 34). SpoVTCT with a molecular weight of 13.5 kDa (123 amino acids) forms a central 
five-stranded anti-parallel β-sheet with the strand order β6-β5-β9-β8-β7 (Fig. 34) flanked 
on one side by an anti-parallel two-helix bundle which comprises the N- (α2, residues 1-
13) and C-terminus (α5, residues 104-123) of the domain (Fig. 34a). On the other side of 
the core β-sheet, another pair of helices (α3 and α4), however, much smaller in length, 
and an extended β7-β8 loop (Fig. 34b) co-build the potential ligand binding pocket of 
the GAF domain (Fig. 34a). The negatively charged protein domain (see Fig. 31a) with a 
surplus of 10 charges (11 positively and 21 negatively charged residues) shows 
hydrophobic patches arranged around the helix bundle (in particular α5) and central 
parts of the β-sheets which are not solvent accessible (data not shown). The presumed 
ligand binding pocket of SpoVTCT is covered with hydrophobic residues (Leu75, Ile98, 
Leu102, Val120, Leu122, Val135, Val149, and Phe151) (see 4.3, Fig. 44). 
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GAF domains are present in diverse transcription factors families and mainly act as 
SSDs. HHpred analyses (Söding et al., 2005) of SpoVTCT show high similarity to YebR, an 
E. coli protein with unknown function representing a GAF fold (PDB entry 1VHM). A DALI 
database search (Holm and Sander, 1993) spotlights TM-IclR (Thermotoga maritima 
isocitrate lyase regulator) (PDB entry 1MKM) (Zhang et al., 2002) with a Z-score of 13.2, 
and CodY, a global regulator of B. subtilis (PDB entry 2B18 and 2HGV) (Levdikov et al., 
2006) with a Z-score of 11.0. The C-terminal domain of TM-IclR (IclRCT) mostly resembles 
the structure of profilin (PDB entry 3NUL and 1FIL). The structural similarity to SpoVTCT is 
represented by an r.m.s.d. of 1.5 Å between 101 aligned Cα atoms (Claude et al., 
2004) (see 4.3, Fig. 43). For the N-terminal GAF domain of CodY (CodYNT), an r.m.s.d. of 
1.5 Å over 94 superimposed Cα atoms was observed (Fig. 35a and Fig. 43) (Claude et 
al., 2004). 
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Despite similarities between SpoVTCT and GAF domains of known structure, there is a 
certain lack of substantial sequence similarity. In sequence comparisons, SpoVTCT is 
most similar to the GAF domain of CodY, CodYNT (residues 1-155), (Levdikov et al., 2006) 
showing 46% similarity (14% identity) (Fig. 35b). CodYNT has a three-helix bundle while 
SpoVTCT offers a two-helix bundle represented by the absence of 18 amino acids at the 
N-terminus of SpoVTCT (Fig. 35a and 35b). The result of sequence and structure 
alignments between these two GAF domains is summarised in the surface presentation 
of SpoVTCT in Figure 35c. Notably, no conserved residues were found adjacent to the 
ligand binding pocket, especially in the loop region which presumably locks the pocket 
(Fig. 35c). 
 
 
 
3.4.7 New Dimerisation Mode of GAF Domains 
 
GAF domains are reported to act as multimerisation domains. In SpoVTFL, interaction 
between the helix bundles of the C-terminal GAF domains mediates tetramer formation 
of the transcription factor (see 3.4.2). 
The related CodYNT dimerises via helical interactions similarly. The CodYNT dimer interface 
is an anti-parallel six-helical bundle mediated by the anti-parallel three-helical coiled 
coil of the monomers (see Fig. 35a). Two helices from each monomer form the dimer 
interface as a parallel four-helical coiled coil (Fig. 36a) generating an interface area of 
1050 Å2 (Levdikov et al., 2006). For coiled coils, a helical constitution displaying 
hydrophobic amino acids in positions one and four is characteristic. The helices of 
CodYNT have a hendecad periodicity (11 residue repeat over 3 helical turns = 3.67 
residues per turn, repeat positions a-k, hydrophobic core positions a, d, e, and h) which 
causes a minimal right-handed supercoil with helix crossing angles close to 0°. This is 
quite contrary to the anti-parallel four-helical coiled coil dimer interface of SpoVTCT 
(Fig. 36a). The helices of SpoVTCT have a pentadecad periodicity; 15 residues repeat 
over 4 helical turns resulting in 3.75 residues per turn. The repeat positions are a-o with 
the hydrophobic core positions in a, d, e, h, and l (Fig. 36b). A right-handed supercoil 
with helix crossing angles between 25° and 45° is formed (see Fig. 36a). 
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Figure 36. Details of the Coiled Coil Interface of SpoVTCT and CodYNT. (a) Superposition of the four-helical 
coiled coil dimer interfaces of SpoVTCT (red) and CodYNT (blue). Visible N- and C-termini and first residues of the 
helices, according to their sequence, are indicated. (b) Amino acid sequence of SpoVTCT (top). Residues 
shaping helices of the dimer interface are highlighted in bold red. Amino acids of the helices which adopt 
hydrophobic core positions in the four-helical interface are labelled (a, d, e, h, and l) (bottom). (c) Amino acid 
sequence of CodYNT (top). Residues shaping helices of the six-helical bundle of the dimer are highlighted in bold 
blue. Amino acids of the helices which adopt hydrophobic core positions in the four-helical interface are 
labelled (a, d, e, and h) (bottom). 
 
 
The cores of the helices in SpoVTCT are not in register, but offset (Fig. 36b) which results in 
unusual core geometries, including two layers with complementary x-da packing: 
Leu66 (a) - Ala164 (a), Thr167 (d) and Ser69 (d), Leu70 (e) - Ala168 (e) (Fig. 36b). The 
offset of the cores of the CodYNT helices are shown in Figure 36c (intramolecular coiled 
coil not shown). The coiled coils of CodYNT are fairly uniform in cross section while the 
bundle of SpoVTCT is not uniform, being closer to a square at one end and to a rhombus 
at the other. The vectors connecting the central axes of symmetry-related helices have 
a length ratio of 16 Å to 15 Å in the first core layer (Tyr62 – Phe171) and of 20 Å to 10 Å 
in the last (Ser69, Leu70 – Ala164) (Fig. 36a). In CodYNT, the intermolecular coiled coil 
has an axial ratio of about 14 Å to 17 Å. 
The helical packing mode of SpoVTCT dimers described here presents a new mode of 
dimer formation in GAF domains. 
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3.5 DNA- and Ligand Binding Studies of B. subtilis SpoVT 
 
 
SpoVT is a GAF domain regulated transcription factor (Dong et al., 2004) suggesting that 
the DNA-binding activity of the protein is controlled by sensing a small signal molecule. 
To determine DNA- and ligand binding properties of SpoVT, different appraches to study 
possible interactions were performed. 
 
 
3.5.1 Biochemical Approach 
 
 
3.5.1.1 Limited Proteolysis with Trypsin and α-Chymotrypsin 
 
The apo-form of a protein often shows differences in its conformation compared to the 
holo-form. An elegant method to determine conformational changes of a protein or a 
protein domain induced by ligand binding is provided by limited proteolysis. To 
investigate the ligand binding capacity of SpoVT, limited proteolysis was performed with 
a subset of presumed ligands and trypsin and α-chymotrypsin (see 6.3.5). Both enzymes 
are serine endopeptidases; trypsin hydrolyses peptide bonds predominantly at the 
carboxyl side of the amino acids lysine and arginine, except in case proline follows, and 
α-chymotrypsin affects the carboxyl side of tyrosine, tryptophan, and phenylalanine. The 
studies were done with the isolated SpoVTCT domain and SpoVTFL. The set of tested 
potential binding partners included cGMP, GTP, DPA, isoleucine, and valine. DNA 
fragments specifying the sequence of the SpoVT promoter region (see 2.4.2 and 
6.1.1.1) were added to the reaction batches containing SpoVTFL. Representatively for all 
performed experiments, Figure 37 shows SDS-PAGE analyses of limited proteolysis 
experiments done with SpoVTFL incubated with DNA and isoleucine (Fig. 37a) and 
SpoVTCT incubated with valine (Fig. 37b). The gels present the cleavage patterns of 
trypsin and α-chymotrypsin exerted on SpoVTFL and SpoVTCT, respectively. No significant 
differences are visible between samples with and without ligand added. 
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Figure 37. Ligand Binding Studies of SpoVTFL and SpoVTCT. SDS-PAGE analyses of limited proteolysis experiments 
of (a) SpoVTFL including DNA fragment and isoleucine (Ile) as potential ligand and treated with trypsin and (b) 
SpoVTCT containing valine (Val) as potential ligand and treated with α-chymotrypsin. As controls, SpoVT proteins 
without potential ligand and BSA were digested comparatively. Samples taken at different points in time are 
indicated. Proteins of the molecular weight marker (M) are specified (kDa). 
 
 
 
3.5.1.2 Gel Filtration Chromatography 
 
Gel filtration chromatography is another biochemical technique to examine 
conformational changes of a protein or a protein complex. Protein solutions of SpoVTFL 
and SpoVTCT were incubated with solutions including diverse small molecules supposed 
to bind to the GAF domain of SpoVT (see 6.3.1.2). Isoleucine, valine, cGMP, GTP, and 
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DPA were tested and in the case of SpoVTFL, DNA fragments containing the promoter 
sequence of SpoVT (see 2.4.2 and 6.1.1.1) were added. Chromatography of the 
applied solutions resulted in elution profiles which in each case were completely 
identical to the elution profiles of pure protein solutions of SpoVTFL or SpoVTCT presented 
in the gel filtration chromatogram in Figure 14 (see 3.2.2.2) (data not shown). 
 
 
 
3.5.2 Biophysical Approach 
 
 
3.5.2.1 Co-crystallisation and Soaking 
 
Existing crystals of the Se-Met derivate of SpoVTCT were soaked with solutions of 
presumed ligands (cGMP, isoleucine, and DPA) (see 6.4.1.1) and analysed by X-ray 
crystallography methods (see 6.4.1.2). All tested crystals diffracted poorly and the 
collected data were not usable for further processing (data not shown). The micro-
seeding technique was applied to induce crystal growth of crystal seeds obtained from 
existing crystals. Emerging crystals were of bad quality, comparably. 
Attempts for co-crystallisation were done with protein solutions of SpoVTCT and SpoVTFL 
(see 6.4.1.1). SpoVTCT co-crystallisation trials were carried out in the presence of either 
GTP, cGMP, or isoleucine and in the case of SpoVTFL, a DNA fragment presenting the 
promoter region of SpoVT (see 2.4.2 and 6.1.1.1) was added in each case. SpoVTCT 
crystals appeared under several conditions, all of small-sized morphology and very bad 
quality (data not shown). Crystals of SpoVTFL exclusively emerged under known 
conditions (see 3.3.1) with addition of GTP or isoleucine. Processing of the collected X-
ray data and structure determination by molecular replacement (see 6.4.1.3) revealed 
that non of the tested ligand binds to the GAF domain nor DNA-binding to the β-barrel 
of SpoVTNT occurred (data not shown). 
 55
Results 
3.5.2.2 Isothermal Titration Calorimetry (ITC) 
 
Detection of thermal variations which are associated to molecular interaction processes 
is the basic principle of isothermal titration calorimetry. SpoVTFL and SpoVTCT protein 
solutions were titrated with solutions containing molecules which possibly offer a specific 
binding affinity towards the GAF domain of SpoVT (see 6.4.3). GTP, cGMP, isoleucine, 
and valine were tested for both proteins but not any of the experiments significantly 
affirmed ligand binding occurrence (data not shown). 
 
 
Due to the results of ligand binding studies performed with the chemicals cGMP, GTP, 
isoleucine, valine, and DPA, it is assumed that probably none of the tested molecules is 
designated to specifically bind to the GAF domain of SpoVT. 
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4. DISCUSSION 
 
 
4.1 Tetrameric State of B. subtilis SpoVT 
 
 
4.1.1 Biochemical Aspects 
 
 
On the basis of the structures of SpoVTFL and SpoVTCT, secondary structure elements of 
the proteins are summed up to contents of 31% α-helices and 32% β-sheets and 37% 
α-helices and 25% β-sheets, respectively. The content of β-sheet elements of both 
proteins is consistent with values from CD measurements (see 3.2.1) (31% in SpoVTFL and 
25% in SpoVTCT). The α-helical content was estimated to be >10% less in CD analyses 
for both proteins (17% in SpoVTFL and 25% in SpoVTCT) compared to the content 
revealed by the 3D-structures. This divergence probably originates from a misleading 
identification of α-helices as random coiled structures that at the same time would 
explain the unusually high content of random coils in the estimations based upon the 
CD data (33% in SpoVTFL and 31% in SpoVTCT, see Table 1). Generally, estimates with this 
method typically have an uncertainty of +/- 5%. 
 
Further CD measurements, concerning heat denaturing of SpoVTFL and SpoVTCT (see 
3.2.1), provided surprising results with respect to the tetrameric SpoVTFL structure. 
According to the tetrameric assembly, a two-step transition would be expected at 
which first the tetramers would separate into dimers. The first midpoint transition 
temperature of SpoVTFL would be assumed to be higher than for the isolated SpoVTCT 
dimer, because of the two interaction sites between four SpoVTCT domains in the 
tetramer. The unfolding of the tightly connected SpoVTNT domains would present the 
second transition step anticipating a high midpoint transition temperature. 
The determined melting curve of SpoVTFL (see Fig. 12) presents a sigmoid shape 
describing a single-step transition, however. Hence, heat denaturing of the SpoVTFL 
tetramer is supposedly a progress at which dissociation into dimers and monomers 
proceeds simultaneously. 
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In comparison to the dimeric single domain protein SpoVTCT, tetrameric SpoVTFL is 
stablised against heat induced unfolding. This implicates less intra- and/or 
intermolecular interactions of the single domain protein SpoVTCT in contrast to SpoVTFL. 
The SpoVTFL tetramer shows an extensive interaction area of at least 4600 Å
2 which is 
added up by twice the interaction area of SpoVTNT (1690 Å
2) and SpoVTCT (610 Å
2). The 
difference between midpoint transition temperatures of both proteins, which was 323 K 
for SpoVTFL and 314 K for the isolated SpoVTCT domain, was determined to be 9 K (see 
Fig. 12). 
 
Biochemical analyses referring the quaternary structure of SpoVTFL and SpoVTCT showed 
that both proteins form oligomers. Gel filtration chromatography experiments clearly 
demonstrated that SpoVTFL assembles into a tetramer and SpoVTCT into a dimer (see 
3.2.2.2, Fig. 14). The results obtained by crosslinking experiments were consistent as the 
existence of SpoVTFL tetramers and SpoVTCT dimers was proven (see 3.2.2.1, Fig. 13). The 
appearance of further oligomers is presumably due to unspecific linkage of oligomers 
by glutaraldehyde. In particular, for SpoVTFL, the formation of diverse high molecular 
weight oligomers is probably based on the solvent accessible lysines in SpoVTNT. 
Glutaraldehyde uses preferentially primary amino groups of lysines for conjugation of 
proteins. 
 
The efforts in detection of homologous expressed native SpoVT in sporulating B. subtilis 
cells via anti-SpoVT antibodies were not fruitful as described in 3.2.3.4 (see Fig. 19). It is 
assumed, that SpoVT is expressed in such low amounts that detection by western blot 
techniques was not possible. Even at highest expression level of SpoVT (T2.5, see 3.2.3.3, 
Fig. 17) (Bagyan et al., 1996), the sensitivity of the anti-SpoVT antibodies was obviously 
not sufficient to detect SpoVT in the endospores. 
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4.1.2 Structural Aspects 
 
 
Several dimeric transcription factors bind palindromic DNA-sequences spanning a 
region of ~ 20 bps (Baleja et al., 1991; Jordan and Pabo, 1988; Vannini et al., 2002). 
Thereby, the two DBDs dock into two consecutive major grooves (Fig. 38) at a distance 
of ~ 34 Å in B-DNA.  
 
 
 
 
Figure 38. TraR/DNA Complex. Cartoon presentation of the dimeric quorum sensing protein TraR (monomer A in 
yellow and monomer B in green) bound to its target DNA shown as sticks in element colour code (PDB 1H0M). 
 
 
Swapped-hairpin β-barrels require tetramerisation for such an interaction, since each 
DNA-binding domain is itself dimeric, and indeed, AbrB-like transcription factors have 
been found to need tetramerisation for their biological activity (Bobay et al., 2006; 
Strauch et al., 2005; Yao and Strauch, 2005). 
In the crystal structure presented here, the asymmetric SpoVTFL tetramer exposes two 
core SpoVTNT DBDs with a distance of ~ 37 Å between two equal points and the 
potential DNA-binding clefts (the anti-parallel β2/β2’-sheet of SpoVTNT, see 3.4.5.1, 
Fig. 29a) are twisted significantly against each other (Fig. 39). 
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Figure 39. Asymmetric SpoVTFL Tetramer. Cartoon presentation of the asymmetric SpoVTFL tetramer illustrating 
the distortion of the SpoVTNT DBDs. The distance between Val16 of monomer D (blue) and B (green) of 37 Å is 
pointed out as a black line. Monomers are coloured as shown in Figure 25 and visible N- and C-termini are 
labelled. 
 
 
Binding of DNA often induces its bending as a result of the adaption to the proteins 
architecture (Baleja et al., 1991; Chen et al., 2001; Ducros et al., 2001; Steitz, 1990; 
Vannini et al., 2002). In the case of SpoVTFL, the central SpoVTNT DBDs needs to 
conformationally rearrange to bind to a DNA target of about 20 bps. For docking into 
two consecutive major grooves of the B-DNA, the SpoVTNT domains have to rotate and 
reduce their distance by about 3 Å. Flexibility of the SpoVTFL tetramer is ensured by the 
domain inter-connecting linkers which provide conformational freedom between the 
domains (see 3.4.3, Fig. 26a). A defined rotation of SpoVTNT could attain a parallel 
position of the DNA-binding β-barrels in the tetramer which can be reported as a 
conformational restrain for binding two consecutive major grooves of the DNA target. 
Recently, the crystal structures of two transcription factors were solved which show an 
asymmetry in dimer formation. IclR of T. maritima (PDB entry 1MKM) (Zhang et al., 2002) 
is composed of an N-terminally HTH DBD and a C-terminally profilin-like SSD (in this work 
termed as IclRCT, see 3.4.6.2) and was found to be distantly related to SpoVTCT (see 
3.4.6.2 and 4.3, Fig. 43). TraR of Agrobacterium tumefaciens, involved in the quorum 
sensing system, consists of an N-terminal GAF SSD domain and a C-terminal HTH DBD 
(PDB entry 1H0M) (Vannini et al., 2002) (see Fig. 38). The SSD in TraR supports the 
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formation of the dimer (Vannini et al., 2002) (see Fig. 38) and in TM-IclR, they 
presumably mediate tetramerisation (Zhang et al., 2002) (Fig. 40). 
 
 
 a b 
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Figure 40. Oligomers of TM-IclR. Cartoon presentation of the (a) dimeric and (b) tetrameric transcription factor 
IclR of T. maritima (PDB 1MKM). Monomers are in different colours and in (a), domains are indicated. 
 
 
The dimer asymmetry in both structures relies on different conformations of the domain 
connecting linkers and in both cases the asymmetry implies biological relevance. In 
TraR, an elongated and a compact monomer form the dimer (see Fig. 38) which leads 
to a defined orientation of the exposed DBDs. Thereby, a precise binding to its 
recognition site by docking into the two consecutive major grooves of the DNA segment 
is enabled (Vannini et al., 2002). Based on particular crystal contacts, in TM-IclR the two 
asymmetric dimers assemble into a tetrameric complex in conjunction with ligand and 
DNA-binding processes (Zhang et al., 2002). Their presented TM-IclR model shows a 
tetramer which exposes two dimeric DBDs in a parallel orientation perfectly arranged to 
dock into two consecutive major grooves of B-DNA (Fig. 40b). 
For SpoVTFL, it was shown that in vitro neither a DNA-binding specificity nor a DNA-binding 
activity exists (Dong et al., 2004). The authors revealed that SpoVTFL exclusively displays 
DNA-binding activity when SpoVTCT is missing. Interestingly, an attended loss of binding 
specificity was noted for the truncated SpoVTFL protein. Based on the determined 
structure of SpoVTFL, the prevented DNA-binding capacity of SpoVTFL derives from the 
distortion of the SpoVTNT DBDs in the asymmetric tetramer (see Fig. 39). The unspecific 
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DNA-binding activity of the truncated SpoVTFL is presumably due to the surface 
properties of swapped-hairpin β-barrels which are predestined to bind to DNA even as a 
dimer (see 3.4.5.1, Fig. 30 and 4.2, Fig. 42). The DNA-binding specificity of the 
transcription factor is facilitated by the tetramerisation which is mediated by the SpoVTCT 
domains. According to this, the conformation of the asymmetric SpoVTFL tetramer 
presented here, is supposed to represent an inactive form of SpoVTFL. 
The formation of the asymmetric dimers within the tetrameric SpoVTFL complex is likely 
based on several salt bridges arranged by amino acids which are conserved 
throughout SpoVT orthologs (see 3.4.3, Fig. 27b). The interaction between and within the 
S monomers (see 3.4.3) seem to lock the tetramer in its asymmetric arrangement. 
These contacts have to disrupt in a putative rotational movement process of SpoVTNT 
leading to the critical parallel orientation essential for DNA-binding. The role of the 
residues mediating these interactions could be tested by mutagenesis. Investigations on 
the DNA-binding properties of such mutants would be a challenge, probably providing 
informative insights into the functionality of SpoVT. 
 
 
 
4.2 DNA-binding Domain (DBD) of B. subtilis SpoVT 
 
 
In B. subtilis, there are 237 DNA-binding transcription factors which are induced during 
the life cycle of the cell (Moreno-Campuzano et al., 2006). In the sporulation process, 
at least five DNA-binding proteins and five RNAP sigma factors are known to govern the 
tightly controlled cell differentiation scenario (Wang et al., 2006). 
The structure of one of these, the σG-dependent transcription factor SpoVT presented in 
this work, is remarkable as it combines structural features of two other regulators of 
B. subtilis. SpoVTNT closely resembles the transition state regulator AbrB in structure and 
sequence (see 3.4.6.1, Fig. 33) while SpoVTCT is similar to the CodY regulator, which is a 
sentinel of the nutrient state, in structure (see 3.4.6.2, Fig. 35) but only distantly in 
sequence. 
The considerable similarity between SpoVTNT and AbrBNT strongly supports the hypothesis 
that the two regulators have similar DNA-binding properties (Dong et al., 2004; Xu and 
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Strauch, 2001). Exposed arginine residues along one face of the swapped-hairpin β-
barrel most likely play an essential role (Bobay et al., 2005; Vaughn et al., 2000). The 
conserved arginines in the anti-parallel β2/β2’-sheet (see 3.4.6.1, Fig. 33a and Fig. 41) 
are suitably oriented for docking into the major groove of B-DNA, as verified for AbrB and 
those located in the capping α-helices support the DNA-binding interactions, as 
proposed for AbrB (Bobay et al., 2005; Strauch et al., 2005). Similar features are 
observed in another swapped-hairpin transcription factor, MazE (see 3.4.6.1 and 
Fig. 41), which acts as the antidote of a toxin/antitoxin system (Kamada et al., 2003; 
Loris et al., 2003). MazENT shows DNA-binding activity by well-oriented arginines (Loris et 
al., 2003) (Fig. 41a). The binding to an “alternating palindrome” promoter sequence by 
docking into the major groove of DNA, is mediated by the β-hairpins of MazENT (Loris et 
al., 2003) which are comparable to the β1-β2/β1’-β2’ loops in SpoVTNT (Fig. 41a). 
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Figure 41. DBDs of SpoVT, AbrB, and MazE. (a) Ribbon representation of superposed dimeric SpoVTNT (red), 
AbrBNT (blue) (PDB entry 1YSF), and MazENT (green) (PDB entry 1MVF) with arginines shown as sticks. Arginines of 
AbrBNT and MazENT involved in DNA-binding are labelled. Side chain of MazENT R8’ presents Cβ and Cγ atoms only. 
(b) Sequence alignment of B. subtilis SpoVTNT (SNT_BACSU), B. subtilis AbrBNT (ANT_BACSU), and E. coli MazENT 
(MNT_ECO). Colour-coding is based on ClustalW (Higgins et al., 1994); (*) invariant, (:) strongly conserved, and (.) 
semi-conserved amino acids. 
 
 
The DNA-binding specificity of SpoVTFL can be described as a “limited promiscuity” 
similar to that of AbrB (Bobay et al., 2006, Bobay et al., 2004); in both cases, the target 
promoters lack recognisable consensus binding motifs (Dong et al., 2004). Promoter 
sequences of the genes which are regulated by SpoVTFL via recruiting the σG subunit of 
the RNAP show no consistent sequence pattern. 
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For the paralogs AbrB and Abh, which are very similar in sequence and structure, 
investigations on their different DNA binding properties were done (Bobay et al., 2006). 
Abh, the second structurally described AbrB-like transcription factor, is another transition 
state regulator in B. subtilis (Bobay et al., 2006). AbrB and Abh show in their N-terminal 
regions (residues 1-54, referred to as AbrBNT and AbhNT, respectively) 70% sequence 
identity with non homologous residues present near the N- and C-termini and in the 
linker region between the α-helix and the β3-sheet. Structural variations between the two 
swapped-hairpin β-barrels are described for the important arginines Arg8, Arg15, Arg23, 
and Arg24 (Fig. 42). In particular, a significant reorientation of the α/β3-linker was 
detected. Together with denotative differences in their surface charge potentials 
(Fig. 42), a correlation to their different DNA-binding specificities is drawn (Bobay et al., 
2006). 
SpoVTNT and AbrBNT vary in the amino acid composition of the linker which connects the 
α1-helix to the β3-strand as well. In SpoVTNT, this linker interacts with the α1-helix for 
stabilisation and possibly plays an important role in the flexibility of the helix relative to 
the β-barrel. Compared to AbrBNT, the α-helices of SpoVTNT provide a significant 
enhancement in negative charges which is based on the two additional arginines 
Arg27 and Arg29 (Fig. 42). The DNA-binding specificity of swapped-hairpin β-barrels 
might be dependent on the mobility and the charge property of their helices which 
leads to varying interactions with the DNA. For AbrB, an important role of the arginines 
Arg25 and Arg26 in DNA-binding was confirmed already (Vaughn et al., 2000). The 
positively charged helices of swapped-hairpin β-barrels probably support the 
adjustment of the anti-parallel β-sheet (β2 and β2’) which exposes the arginines well-
positioned to dock into the major groove of B-DNA. 
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Figure 42. Surface Charge Potentials of DBDs of SpoVT, AbrB, and Abh. Surface representations of SpoVTNT (left), 
AbrBNT (PDB entry 1YSF) (middle), and AbhNT (PDB entry 2FY9) (right) illustrating their surface charge potentials with 
view onto the anti-parallel β2/β2’-sheets. Arginines are marked and surface charge potentials are coloured in 
blue and red for basicity and acidity, respectively (values coloured from -10 (red) to 10 (blue) kT/e). 
 
 
Generally, β-sheets which represent the structural DNA-binding motif are rather rare in 
bacteria. The swapped-hairpin β-barrel describes a new β-sheet based DNA-binding 
motif and thus, determination of a complex structure with DNA would be of great 
interest. 
 
 
 
4.3 Signal Sensing Domain (SSD) of B. subtilis SpoVT 
 
 
SpoVT is the first structurally described protein which couples a swapped-hairpin β-barrel 
with a GAF domain. 
GAF domains are SMBDs, “…whose principal biochemical role is to exert a regulatory 
effect and/or transmit signal by binding a small molecule” (Anantharaman, 2001). 
Within the SMBDs, GAF domains represent one of the largest and most widespread 
groups of SSDs and are especially prominent among bacteria (Anantharaman, 2001). 
The similarity between different GAF domains is structure based while sequence 
similarities are not frequent (Ho et al., 2000). The basic fold of GAF domains is a central 
anti-parallel β-sheet which is surrounded by α-helices. 
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The SSD of SpoVT, SpoVTCT, shows structural similarities to the GAF domain CodYNT and 
the profilin-like IclRCT, demonstrated by their superpositions depicted in Figure 43a. In 
respect of their sequences, they appear rather divergent (Fig. 43b). 
 
a b  
 
 
Figure 43. SSDs of SpoVT, CodY, and IclR. (a) Ribbon representation of superposed SpoVTCT (red), CodYNT (PDB 
entry 2B18) (blue), and IclRCT (PDB entry 1MKM) (green) with ligand binding pocket marked by an ellipse. (b) 
Sequence alignment of SpoVTCT (residues 56(1)-178(123); SCT_BACSU) and CodYNT (residues 1-155, CNT_BACSU) 
of B. subtilis and IclRCT of T. maritima (residues 76(1)-228(153), ICT_THEMA). Colour-coding is based on ClustalW 
(Higgins et al., 1994); (*) invariant, (:) strongly conserved, and (.) semi-conserved amino acids. 
 
 
The structural similarity between SpoVTCT, CodYNT and IclRCT is restricted to the central 
anti-parallel β-sheet and the helix bundles which are placed to one side side of the β-
sheets (r.m.s.d. of 1.5 Å, see 3.4.6.2). The potential ligand binding pockets, shaped at 
the other side of the β-sheet, differ clearly among each other (Fig. 43a). Especially IclRCT 
distinguishes from SpoVTCT and CodYNT, regarding secondary structure elements defining 
the binding pocket. 
GAF domains in their holo-form show the small molecule usually deeply embedded in 
the binding pocket (Vannini et al., 2002) and enclosed by loops and helices via a 
“clamp mechanism” (Zhang et al., 2002). IclRCT (PDB entry 1MKM) binds a Zn atom in its 
binding pocket (Zhang et al., 2002), the TraR GAF domain locks the autoinducer N-(3-
oxo-octanoyl)-L-homoserine lactone (Vannini et al., 2002), and the GAF-A/B domains 
from the product of the Anabaena adenylyl cyclase cyaB2 gene bind negatively 
charged cyclic nucleotides. The ligand binding pocket of the cyaB2 GAF domains is a 
partially charged cavity (Martinez et al., 2005) shaped by small residues mainly (Fig. 44). 
SpoVTCT and the related CodYNT (see 3.4.6.2) show a hydrophobic binding pocket partly 
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defined by bulky residues (i.e. Leu75, Ile98, Val120, and Phe151 in SpoVTCT and Phe40, 
Val42, Leu79, and Ile113 in CodYNT) (Fig. 44). 
 
 
CodYNTSpoVTCTcyaB2CT GAF B  
 
Figure 44. Ligand Binding Pockets of GAF Domains. Cartoon illustration of the GAF B domain of the product of 
the Anabaena adenylyl cyclase cyaB2 gene (PDB entry 1YKD) (cyaB2CT GAF B, left, green), SpoVTCT (middle, red), 
and CodYNT (PDB entry 2B18) (blue, right). Relevant residues of the ligand binding pocket are shown as sticks in 
element colour code. 
 
 
CodY is known to sense intracellular GTP and BCAA levels (Ratnayake-Lecamwasam et 
al., 2001). An additive effect of both ligands on CodY was proven recently and hence, 
different binding sites for both ligands were assumed (Handke et al., 2008). Lately, the 
structure of the holo-form of CodYNT was solved (Levdikov et al., 2006) which revealed 
the binding mode of the BCAAs valine and isoleucine to the ligand binding pocket. 
Both hydrophobic amino acids seemed to be attached to the binding pocket rather 
than enclosed (for isoleucine see Fig. 45). Thereby, the extensive β3-β4 loop of the 
CodYNT binding pocket (residues Ile91-Pro99, (Levdikov et al., 2006), see 3.4.6.2, 
Fig. 35b) was bended inwardly (PDB entry 2B18 with isoleucine and 2HGV with valine) 
(Fig. 45). The superposition of SpoVTCT and holo-CodYNT in Figure 45 clearly demonstrates 
the differences in the conformation of the structural elements which define the 
particular ligand binding pocket. In SpoVTCT, the β7-β8 loop is stretched out and the 
“clamp” (α4-helix and β7-β8 loop) is closed compared to the open arrangement of the 
β3-β4 loop and the α4-helix in CodYNT (Levdikov et al., 2006). 
 
 67
Discussion 
 
α4
α4
α4
α4
 
 
Figure 45. GAF Domains of SpoVTCT and CodYNT. Superposition of SpoVTCT (red) and CodYNT (blue) with isoleucine 
bound to CodYNT (PDB entry 2B18) (left); zoom-in into the binding pocket with CodYNT bound isoleucine (right). 
Isoleucine is represented in gold coloured sticks. α-helix involved in “clamp mechanism” (α4) is labelled for each 
domain. 
 
 
It is assumed that this “closed” state of SpoVTCT presents its apo-form and that a yet 
unknown molecule will bind in a regulatory capacity. The regulatory effect is thought to 
be caused by conformational changes throughout the SpoVTCT domain. For the 
homologous CodYNT, conformational changes induced upon binding of BCAAs are 
known (Levdikov et al., 2006). In SpoVTFL, those rearrangements within SpoVTCT 
supposedly are translocated all over the protein and consequently, all over the 
tetrameric complex which then induce the DNA-binding activity of SpoVT. 
 
 
 
4.4 Dimerisation Mode of GAF Domains in B. subtilis SpoVT 
 
 
In addition to signal sensing, SSDs of transcription factors can be involved in the 
formation of oligomeric structures (see 4.1.2). In particular, GAF domains can act as 
multimerisation domains presenting a broad variety in the adopted multimerisation 
modes (Ho et al., 2000; Levdikov et al., 2006; Martinez, Wu et al., 2002; Vannini et al., 
2002; Zhang et al., 2004). 
Ho et al. published in the year 2000 the crystal structure of the YKG9 protein of 
Saccharomyces cerevisiae as the first structurally characterised GAF domain. The 
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protein with an unknown function was discovered to form an anti-parallel dimer with an 
interface formed by α-helices, β-sheets and loops (Ho et al., 2000). In 2002 and 2005, 
structures of GAF domains of the mouse PDE-2A and of the product of the adenylyl 
cyclase gene cyaB2 of the cyanobacterium Anabaena, respectively were published by 
Martinez et al. Both proteins are dimers of tandem GAF-A/B domains. The PDE dimer is 
arranged in a parallel manner, while the adenylyl cyclase forms an anti-parallel dimer. 
The interaction of the monomers in both proteins occurs mainly through helical 
interactions and is entirely different to the YKG9 protein (Martinez et al., 2005; Martinez, 
Wu et al., 2002). 
A helical interaction between GAF domains forming a four-helical coiled coil interface 
was recently published by Levdikov et al. (Levdikov et al., 2006) which is most similar to 
the dimer interface of SpoVTCT (see 3.4.7, Fig. 36). In both proteins, the GAF domains are 
in an anti-parallel orientation but the interface of CodYNT describes a parallel four-helical 
coiled coil in contrast to an anti-parallel four-helical coiled coil of the SpoVTCT dimer. 
Both dimers form a right-handed supercoil due to the helical interactions but they show 
tremendous differences in their helix crossing angles (described in detail in 3.4.7). While 
in CodYNT the monomers interact by a fairly straight arrangement, monomers of the 
SpoVTCT dimer are significantly twisted against each other (Fig. 46). 
 
 
90°90°
 
 
Figure 46. SpoVTCT and CodYNT Dimers. Superposition of dimers of SpoVTCT (red) and CodYNT (PDB entry 2B18) 
(blue) with sight at the dimer interface (left) and onto the interface mediating helix bundles (right). 
 
 
The core geometries of the SpoVTCT dimer interface include two layers with 
complementary x-da packing (see 3.4.7, Fig. 36), a helical conformation found in 
merely a few coiled coil structures (Hulko et al., 2006). The CodYNT coiled coil adopts the 
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energetically advantageous canonical knobs-into-holes conformation in an unusual 
parallel helix arrangement (Gruber and Lupas, 2003). 
Because of the different geometry of the dimer interface which was discovered for 
SpoVTCT, it is stated that the dimerisation mode presented here is new in interacting GAF 
domains. For SpoVTFL, this extraordinary arrangement is probably somehow decisive for 
the regulatory function. 
 
 
 
4.5 Model for SpoVT Mediated Regulation 
 
 
The findings about the σG-dependent forespore-specific transcriptional regulator SpoVT 
presented in this work, together with already known data of the protein, confirm the 
assumption that SpoVT is a GAF domain regulated transcription factor. 
 
The described asymmetric SpoVTFL tetramer, which is denoted as the inactive state of 
SpoVT (see 4.1.2), supports the observations that SpoVTFL does not bind to DNA in vitro. It 
is suggested, that the distortion of the two swapped-hairpin DBDs in the SpoVTFL tetramer 
hampers docking into two consecutive major grooves of specific DNA recognition sites. 
The asymmetic spiral-form of the complex is adhered by several intra- and 
intermolecular contacts, which are supposed to be responsible for the prevented 
adaption to the DNA segment. 
Investigations on the SpoVTCT domain discovered a new dimerisation mode for GAF 
domains with an uncommon interaction geometry. This feature is addressed to be 
somehow decisive for the switch between the inactive and active form of SpoVTFL. 
The idea that SpoVT is a GAF domain regulated transcription factor is confirmed by the 
structure of SpoVTCT revealing a GAF fold. Despite the failure of identification of the small 
molecule which specifically binds to the SpoVTCT GAF domain for regulatory effects, it is 
strongly believed that this is the key step in activation of SpoVT. 
 
Based on those data, a model for the SpoVT mediated transcriptional regulation has 
been developed (Fig. 47). 
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The asymmetric conformation of tetrameric SpoVTFL is adversarial to bind to specific 
DNA targets. In this inactive state, SpoVTFL is unable to exert its regulatory function 
(Fig. 47, left). At a definite status during the sporulation progress, a certain signal 
molecule is present at a high concentration in the forespore chamber (Fig. 47, middle). 
The molecule binds specifically to the ligand binding pocket of the SpoVTCT GAF 
domains in the SpoVTFL tetramer. The ligand binding process induces conformational 
changes within the SpoVTCT GAF domains which are transferred to the SpoVTNT DBDs via 
the domain connecting linkers. Upon this, specified interactions within the tetrameric 
complex are impaired which enables SpoVTNT DBDs to rearrange in a concerted action. 
A symmetric SpoVTFL complex with a parallel alignment of the SpoVTNT DBDs is formed 
(Fig. 47, right). This conformation of the SpoVTFL tetramer features a high affinity towards 
specific DNA segments which represents the active form of SpoVTFL. The accurately 
arranged swapped-hairpin DBDs dock into two consecutive major grooves of a DNA 
section presenting a compatible sequence pattern (Fig. 47, right). The transcription of 
genes, whose products are necessarily used in the forespore development, is initiated. 
 
 
 
 
Figure 47. Model of Proposed Mechanism for SpoVTFL Mediated Transcriptional Regulation. Scheme of 
proposed functionality of tetrameric SpoVTFL. Inactive SpoVTFL (left) is activated upon ligand binding and DNA-
binding is induced (right). SpoVTFL tetramer is coloured by subunits (according to Figure 24) with SpoVTCT SSDs as 
filled circles (left) or ellipses (right) and SpoVTNT DBDs as l-shaped bricks. Stabilisation of the asymmetric tetramer is 
represented by filled yellow and red triangles (left). The putative SpoVT specific ligand is depicted as filled black 
triangles and DNA is indicated as a dotted line with a grey bar framed in orange illustrating the DNA recognition 
site. 
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5. MATERIALS 
 
 
5.1 Chemicals and Reagents 
 
 
 
 
Substance   Provider            Substance             Provider 
β-mercaptoethanol   Merck 
Acrylamide (Protogel)  Roth 
Ammoniumpersulfate  Merck 
Bromophenol blue  Merck 
CaCl2    Merck 
cGMP    Sigma 
Coomassie Brilliant Blue R-250 Serva 
CuSO4    Sigma 
Dipicolinic acid   Sigma 
DTT    Merck 
EDTA    Merck 
Eosine    Sigma 
Ethanol    Riedel-de Haën 
FeSO4    Sigma 
Glacial acid   Fluka 
Glutaraldehyde, 
25% aqueous solution  Merck 
Glycerol   Riedel-de Haën 
Glycine    Merck 
GTP    Sigma 
HCl    Merck 
Imidazole   Merck 
Isoleucine   Fluka 
K2HPO4    Merck 
KCl    Merck 
KH2PO4    Merck 
Malachite green  Sigma 
Methanol   Merck 
MgCl2    Merck 
MgSO4    Merck 
MnCl2    Sigma 
MOPS    Biomol 
Na2HPO4   Merck 
NaCl    Merck 
NaH2PO4   Merck 
NaOH    Merck 
PEG 200   Fluka 
PEG 600   Fluka 
SDS    Serva 
Sulfosalicylic acid  J. T. Baker 
TCA    Riedel-de Haën 
TEMED    Serva 
Tris, Trizma   Merck, Sigma 
Triton X-100    Sigma 
Tween 20   Sigma 
Valine    Fluka 
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5.2 Kits and Materials 
 
 
Kits: 
 
 Kit        Provider 
ABI Prism Big Dye Terminator version 3.1    Perkin Elmer Applied Biosystems 
Champion pET100 Directional TOPO Expression Kit  Invitrogen 
Crystallisation Kits Hampton Research, Sigma, Jena 
Biosciences, Emerald BioSystems 
LMW Gel Filtration Calibration Kit    Amersham Biosciences 
NativePAGE        Invitrogen 
NuPAGE Bis-Tris Gel System     Invitrogen 
PCR Master Mix and H2O     Roche 
QIAprep Spin Miniprep Kit     Qiagen 
QIAquick PCR Purification Kit     Qiagen 
 
 
Materials: 
 
r  Material       Provide
 
Affi-Gel beads       Bio-Rad 
BSA        Serva 
Cellulose membrane dialysis tubing    Sigma 
Complete protase inhibitor cocktail    Roche 
Concentrators       Amicon Millipore 
Crystallisation material and tools    Hampton Research 
DNase        Roche 
Freundsches Adjuvant incomplete    Sigma 
Horseradish peroxidase, goat anti rabbit   Sigma 
Kanamycin       Sigma 
Lysozyme       Merck 
Molecular weight marker     Fermentas 
Ni-NTA superflow beads      Qiagen 
PVDF membrane      Millipore 
Slide-A-Lyzer dialysis cassettes     Pierce 
Titermax Gold       Sigma 
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Trypsin        Roche 
Whatman paper 3MM      VWR 
α-chymotrypsin       Sigma 
 
 
5.3 Media, Buffers, and Solutions 
 
5.3.1 Growth Media 
 
Prepared growth media were autoclaved at 394 K and 2 bar for 20 min. Liquid growth 
media were routinely sterilised in Schikane flasks. Antibiotics for selection were added to 
cooled medium shortly before inoculation if necessary. In the case of media for agar 
plates, antibiotics were added at a temperature of ~ 323 K prior to pouring. 
 
5.3.1.1 LB Medium 
 
Luria Bertani (LB) medium for E. coli and B. subtilis: 
 
1% (w/v)  bacto tryptone (Becton, Dickinson and Company) 
0.5% (w/v)  bacto yeast extract (Becton, Dickinson and Company) 
1% (w/v)  NaCl (171 mM) 
 
pH 7.0, adjusted with NaOH 
 
5.3.1.2 TB Medium 
 
Terrific broth (TB) medium for E. coli: 
 
1.2% (w/v)  bacto tryptone (Becton, Dickinson and Company) 
2.4% (w/v)  bacto yeast extract (Becton, Dickinson and Company) 
0.4% (w/v)  glycerol 
 
pH 7.5, adjusted with 100 mM KH2PO4/K2HPO4 buffer 
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5.3.1.3 DSM Medium 
 
Difco sporulation medium (DSM) for B. subtilis: 
 
0.8% (w/v)  nutrient broth (Fluka) 
0.1% (w/v)  KCl (13.4 mM) 
0.025% (w/v)  MgSO4 (2.1 mM) 
 
Supplements: 
1 µM    MnCl2
0.1 mM   CaCl2
0.1 µM   FeSO4
 
Respective amounts of the filter-sterilised supplement stock solutions (see 5.3.3) were 
added after autoclaving. 
 
 
5.3.1.4 LB Agar Plates 
 
1% (w/v)  bacto tryptone (Becton, Dickinson and Company) 
0.5% (w/v)  bacto yeast extract (Becton, Dickinson and Company) 
1.5 g (w/v)  bacto agar (Becton, Dickinson and Company) 
1% (w/v)  NaCl (171 mM) 
 
pH 7.0, adjusted with NaOH 
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5.3.2 Buffers 
 
Method Abbreviation Composition 
   
Ni-NTA buffers (NB) 
pH 8.0, adjusted with NaOH 
NB 1 50 mM NaH2PO4, 300 mM NaCl, 
10 mM imidazole 
 NB 2 50 mM NaH2PO4, 300 mM NaCl, 
30 mM imidazole 
 NB 3 50 mM NaH2PO4, 300 mM NaCl, 
500 mM imidazole 
10x PBS buffer 
pH 7.3, adjusted with K2HPO4
PBS 140 mM NaCl, 2.7 mM KCl, 10 mM 
Na2HPO4, 1.8 mM KH2PO4
Antibody purification buffers (AB) AB 1 1 M Tris-HCl pH 7.5 
 AB 2 10 mM Tris-HCl pH 7.5, 100 mM 
NaCl 
 AB 3 10 mM Tris-HCl pH 7.5, 1 M NaCl 
 AB 4 1 M Tris-HCl pH 8.0 
SDS-PAGE buffers (SPB) SPB 1 250 mM Tris-HCl pH 8.0, 7.5% (w/v) 
SDS, 12.5% β-mercaptoethanol, 
25% glycerol, 0.025% bromo-
phenol blue 
 SPB 2 250 mM Tris-HCl pH 6.8, 0.5% (w/v) 
SDS, 0.96 M glycine 
 SPB 3 1.5 M Tris-HCl pH 6.8, 0.5 mM EDTA, 
0.4% (w/v) SDS 
 SPB 4 1.5 M Tris-HCl pH 8.8, 0.5 mM EDTA, 
0.4% (w/v) SDS 
Electro blotting buffers (EB) EB 1 300 mM Tris-HCl pH 10.4 
 EB 2 25 mM Tris-HCl pH 10.4 
 EB 3 25 mM Tris-HCl pH 9.4, 40 mM ε-
aminocaproic acid 
Western blotting buffers (WB) WB 1 10 mM Tris-HCl pH 7.5, 150 mM 
NaCl 
 WB 2 10 mM Tris-HCl pH 7.5, 150 mM 
NaCl, 3% (w/v) BSA 
 WB 3 20 mM Tris-HCl pH 7.5, 500 mM 
NaCl, 0.2% (v/v) Triton X-100, 0.05% 
(v/v) Tween 20 
MOPS buffer 
pH 7.25, adjusted with NaOH 
MOPS 20 mM MOPS, 120 mM NaCl 
Limited proteolysis buffers (LPB) LPB 1 20 mM Tris-HCl pH 8.0, 1 mM 
MgCl2, 1 mM DTT, 0.5 mM EDTA 
 LPB 2 20 mM Tris-HCl pH 8.0, 1 mM 
MgCl2, 1 mM DTT, 2 mM CaCl2
Spore buffers (SB) SB 1 10 mM NaH2PO4/Na2HPO4 pH 7.2 
 SB 2 10 mM NaH2PO4/Na2HPO4 pH 7.2, 
1% (w/v) lysozyme, complete 
protase inhibitor cocktail 
 SB 3 10 mM NaH2PO4/Na2HPO4 pH 7.2, 
500 mM NaCl 
 SB 4 6 M urea, 50 mM DTT, 1% (w/v) SDS, 
pH 10.0 
Microseeding buffer 
pH 7.5, adjusted with NaOH 
MSB 100 mM HEPES, 25% (w/v) 
PEG 3350, 200 mM NaCl 
 
Table 5. Buffers. 
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5.3.3 Solutions 
 
• 0.025% Glutaraldehyde 
• 0.1% Coomassie Brilliant Blue R250 in water:methanol:glacial acid = 45:45:10 
• 100 mM Glycine pH 2.8 
• 2% (w/v) Ponceau S in TCA : sulfosalicyl acid : ddH2O = 30 : 30 : 40 
• 2.5% (w/v) Eosine 
• 3% (w/v), 10% (w/v), or 200 mg*ml-1 BSA in 10 mM Tris-HCl pH 7.5, 150 mM NaCl 
• 4% (w/v) CuSO4 
• 5% (w/v) Malachite green 
• Coomassie destain: water : methanol : glacial acid = 45 : 45 : 10 
• Pre-cast BCA (Sigma) 
• SuperSignal West Pico Chemiluminescent Substrate (Pierce) 
 
 
Stock solutions: 
 
• 0.1 M CaCl2 
• 0.1 mM FeSO4 
• 1 M IPTG 
• 1 mg*ml-1 α-chymotrypsin 
• 1 mg*ml-1 Trypsin 
• 1 mM MnCl2 
• 10 mg*ml-1 Kanamycin 
• 100 mM cGMP 
• 100 mM DPA in 2.5  N NaOH or MeOH 
• 100 mM GTP 
• 100 mM Isoleucine 
• 100 mM Valine 
• 10xPBS buffer (see 5.3.2); for 1x PBS buffer, stock solution was diluted 1:10 with ddH2O. 
• 5% Lysozyme 
 
Substances were dissolved in water, filter-sterilised, distributed to aliquots, and stored at 
277 K or 253 K. 
 77
Materials 
5.4 Strains, Plasmids, and Oligonucleotides 
 
 
5.4.1 Strains 
 
B. subtilis 168 
Colonies of Bacillus subtilis subsp. subtilis strain 168 on an agar plate were a 
thanksworthy donation by Dr. Janine Kirstein (Freie Universität Berlin). 
 
E. coli chemically competent DH5α cells 
Library efficiency DH5α competent cells (Invitrogen) 
F- φ80lacZ∆M15 ∆(lacZYA-argF)U169 recA1 endA1 hsdR17(rk-, mk+) phoA supE44 thi-1 
gyrA96 relA1 λ-
 
E. coli chemically competent BL21 Star (DE3) cells 
BL21 Star (DE3) one shot chemically competent E. coli (Champion pET100 Directional 
TOPO Expression Kit, Invitrogen) 
F- ompT hsdSB (rB
-mB
-) gal dcm rne131 (DE3) 
 
 
5.4.2 Vector 
 
To create constructs for the overexpression of the His6-SpoVTFL and the His6-SpoVTCT 
protein, the vector pET30b(+) (Novagen) (Fig. 48) was used. The spoVT open reading 
frame was amplified from Bacillus subtilis strain PY79 (prototroph, derived from strain 
168, (Youngman et al., 1984)). The genes his6-spoVTFL and his6-spoVTCT were cloned into 
the vectors digested with NdeI and XhoI. Cloning procedures were carried out by Dr. 
Sergej Djuranovic, MPI for Developmental Biology, Tübingen* (Djuranovic, 2007). 
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Figure 48. pET-30a-c(+) Vector Map. Vector map of the pET-30a-c(+) vector (Novagen) with kanamycin 
resistance gene (Kan+) for overexpression of fusion proteins with an N-terminal His6-tag in E. coli. Taken from 
http://www.merckbiosciences.co.uk/docs/docs/PROT/TB095.pdf. 
 
 
5.4.3 Oligonucleotides 
 
All oligonucleotides were purchased from Metabion. The desalted solutions provided 
oligonucleotide concentrations of 100 pmol*µl-1. 
 
T7 primer: promoter and terminator sequences for DNA sequencing 
T7 pro (promoter sequence): 5’-TAATACGACTCACTATAGGG-3’ 
T7 term (terminator sequence): 5’-GCTAGTTATTGCTCAGCGG-3’ 
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The oligonucleotides were synthesised in a 0.02 µmol scale. 
 
Primer for DNA-binding tests 
forSpVOp5’ (SpoVT operon sequence forward): 
5’-CGTAAATTTTGTTACTCTCTGGTGTATATTACATTTGATGTGACGGATACTAATTTCAAGCGAG-
GCGGAAGGTACATAAAGTAACTGCTTTAGGTCTTT-3’ 
 
revSpVOp5’ (SpoVT operon sequence reverse): 
5’-AATACGACGTACGATACCGGTTGCTTTCATCTCTGGTGCCTCTCTTTCATTTGATGGTATAT-
ACATGTGGGAAAGACCTAAAGCAGTTACTTTATGTAC-3’ 
 
The oligonucleotides were synthesised in a 0.04 µmol scale. 
 
 
 
 
5.5 Instruments and Devices 
 
Centrifuges: 
• Beckman Avanti J-20XP centrifuge, rotors JA 25.50 and JLA 8.1000 
• Beckman Avanti J-25 centrifuge, rotor JA 25.50 
• Beckman Optima LE-80K ultracentrifuge, rotors 45Ti and 60Ti 
• Eppendorf centrifuge 5417R, rotor F 45-30-11 
• Eppendorf centrifuge 5810 R, rotor A-4-62 
• Hettich Rotixa/KS centrifuge, rotor 5094-684 
• Sigma 4K15 swing-out rotor 
 
SDS-PAGE devices: 
• Gel Electrophoresis System Mighty Small II SE250/SE260 (Hoefer/Amersham Pharmacia 
Biotech AB) 
• Multiple Gel Caster (in house) 
• Power Supply EPS 300 (Pharmacia Biotech) 
• XCell SureLock Electrophoresis Cell (Novex Mini-Cell) (Invitrogen) 
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Semi-Dry Blot Apparatus (in house) 
 
DNA Thermal Cycler (Perkin Elmer) 
 
Spectrometer: 
• CD spectrometer (Spectropolarimeter Jasco J-715, Rev. 1.00, including Peltier element 
controller, JASCO Corporation) 
• Spectrophotometer (ND-1000, NanoDrop Technologies Inc.) 
• UV-Vis spectrometer, Ultrospec II (LKB Biochrom) 
 
Isothermal Calorimetry Titrator (MicroCalorimeter VP-ITC, MicroCal) 
 
X-ray Film Developer (X-OMAT 1000 Processor, Kodak) 
 
Shaking Incubator Multitron AJ20 and GFL 3033 (Infors AG) 
 
HPLC: 
• ÄKTA Explorer and ÄKTA Basic High Pressure Liquid Chromatography (HPLC) system 
(Amersham Biosciences) 
• Empty XK columns (Amersham Biosciences) 
• HPLC/Mass Spectrometry (MS) system (Single Quatrupol API 165, Perkin Elmer Sciex; ReflexIII, 
Bruker, Daltronics, Bremen; Ultraflex II TOF/TOF, Bruker Daltronics, Bremen) 
• SMART Chromatography System (Amersham Biosciences) 
• Superdex 75 pre-packed gel filtration columns HiLoad 26/60 prepgrade and PC 3.2/30 
(Amersham Biosciences) 
 
Glass Eono-column column (Bio-Rad) 
 
Microscopes: 
• Light microscope Laborlux D (Leitz) with Hamamatsu Digital Camera C4742-95 
• Light microscope Olympus Optical CO., LTD SZX12-ILLK200 with CCD camera Canon Power 
Shot A620 
 
French Pressure Cell Press (Polytec GmbH, Aminco SLM Instruments) 
 
Varioclav (H + P Labortechnik) 
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5.6 Computational Software 
 
Sequence searches were performed with PSI-Blast server (Altschul et al., 1997) on the 
non-redundant protein sequence database at the National Center for Biotechnology 
Information† and with HHpred (Söding, 2005) on sequences from the Protein Data Bank, 
filtered at 70% sequence identity (PDB70). Sequence alignments were made with 
ClustalW (Higgins et al., 1994). Structure alignments were obtained from DALI (Holm and 
Sander, 1993) and were investigated further using the PISA database (Krissinel and 
Henrick, 2007) and the RMSD calculator (Claude et al., 2004). 
X-ray data were processed using the software mentioned in corresponding chapters. 
DNA sequences were checked with BioEdit. 
Topology diagrams were generated using TopDraw (Bond, 2003) and figures were 
created with PyMOL‡, CorelDraw and PowerPoint. 
 
                                                 
† www.ncbi.nlm.nih.gov 
‡ http://pymol.sourceforge.net/ 
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6. METHODS 
 
 
6.1 Molecular Biology and Microbiology 
 
 
6.1.1 Molecular Biological Methods 
 
 
6.1.1.1 Amplification of SpoVT Operon DNA Sequence by Polymerase Chain 
Reaction (PCR) 
 
The DNA fragment including the SpoVT promoter sequence (see 2.4.2) was produced 
via a polymerase chain reaction (PCR) using overlapping primers (see 5.4.3). 1 µl of 
each of the primer solutions (100 pmol*µl-1) were mixed with 12.5 µl PCR Master Mix and 
filled up to 25 µl with H2Odest (Roche). 
 
The TM was calculated according to the equation 
 
TM = 3*Σ(Ci + Gi) + 2*Σ(Ai + Ti). 
 
 
The PCR was performed according to the the cycle scheme 
 
Denaturation    368 K    30 sec 
Annealing    358 K      5 sec 
Extension    345 K      5 sec 
30 cycles 
 
 
Purification of the PCR reaction products was done using the Qiagen PCR Purification Kit 
following manufacturer´s protocol (see 9.). 
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6.1.1.2 Isolation and Purification of Vector DNA from E. coli 
 
5 ml of LB medium inclusive the relevant antibiotic for selection were inoculated with a 
single colony taken from an adequate LB agar plate. The cells grew overnight at 310 K 
and 200 rpm. Cells were harvested by centrifugation for 10 min at 3220*g and medium 
was decanted. Isolation of vector DNA was done by alkaline lysis of the cells following 
Qiagens QIAprep Spin Miniprep protocol using the commercial available Kit (see 9.). 
 
 
6.1.1.3 Determination of DNA Concentration 
 
DNA concentration was determined photometrically by measurement of the absorption 
of DNA solutions at 260 nm and 280 nm. Absorption of 1 at 260 nm corresponds to a 
solution containing 50 µg*ml-1 DNA. An OD260/OD280 ratio of 1.8 accounts for a solution 
yielding pure double stranded DNA. 
 
 
6.1.1.4 DNA Sequencing 
 
For DNA sequencing, 3 µl (~ 300 ng) of the isolated plasmid DNA obtained from E. coli 
DH5α cells (see 6.1.1.2), were mixed with 1 µl of the 100 pmol*µl-1 primer solutions of the 
T7 promoter and the T7 terminator. To apply the chain-termination method, 
fluorescence labelled 2’,3’-didedoxy nucleotides were added by using 3 µl of the 
BigDye Kit “3.1”. The reaction sample was filled up to 20 µl with ddH2O and reaction was 
processed by following the cycle programme 
 
Initial denaturation   369 K      1 min 
Denaturation    369 K    30 sec 
Annealing    323 K    30 sec 
Elongation    333 K      4 min 
30 cycles 
 
Amplified PCR products were purified and analysed by the in house Core Facility. 
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6.1.2 Microbiological Methods 
 
 
6.1.2.1 Transformation of Chemically Competent E. coli Cells 
 
The plasmids encoding N-terminally His6-tagged SpoVTFL and N-terminally His6-tagged 
SpoVTCT were provided from Dr. Sergej Djuranovic, MPI for Developmental Biology, 
Tübingen* (Djuranovic, 2007). 
 
The transformation procedure of chemically competent E. coli DH5α cells (Library 
Efficiency, Invitrogen) for amplification of vector DNA was done according to 
manufacturer´s protocol (see 9.). 
 
The transformation procedure of chemically competent E. coli BL21 Star (DE3) cells 
(Champion pET100 Directional TOPO Expression Kit, Invitrogen) for protein overexpression 
was done corresponding manufacturer´s protocol “Champion pET Directional TOPO 
Expression” (see 9.). 
 
For selection of transformants, different volumes of the cell suspensions (10, 50, and 
100 µl) were plated onto selective LB agar plates (see 5.3.1.4). Overnight incubation 
was done at 310 K. 
 
LB agar plates were used for short-term storage support of bacterial cells. 
 
 
6.1.2.2 Long-term Stock Cultures 
 
Long-term storage cultures were prepared using liquid cultures. Therefore, DMSO or pre-
sterilised glycerol was added to overnight cultures to a final content of 7% or 30%, 
respectively. After vigorously vortexing, stock cultures were aliquoted and immediately 
frozen in liquid nitrogen and kept at 193 K. 
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6.1.2.3 Cultivation of E. coli and B. subtilis 
 
High density liquid cell cultures of E. coli and B. subtilis were obtained in TB or LB 
medium. A starter culture of 35 ml LB medium containing an adequate antibiotic for 
selection if required, was inoculated with a small amount of cells of thawed stock 
cultures (see 6.1.2.2) or a single colony which was picked from an LB agar plate (see 
6.1.2.1). After incubation overnight at 310 K and 200 rpm, the pre-culture was 
transferred into a larger volume of either TB or LB medium including antibiotic if required. 
For protein overexpression, routinely TB medium was used. 1 l cultures were inoculated 
with one pre-culture and 3 l cultures were inoculated with three pre-cultures, referring to 
an initial OD600 of 0.1 - 0.2. The cultures were incubated at 310 K and 200 rpm. 
Overnight cultures usually obtained an OD600 of approximately 2.5 which corresponds to 
~ 5 g*l-1 cell pellet wet weight. 
 
 
6.1.2.4 Synchronisation of B. subtilis Cells 
 
B. subtilis cells were routinely grown in LB medium. The cells were harvested at OD600 of 
0.7 - 0.8 by centrifugation for 15 min at 6000*g and room temperature. The cell pellet 
was resuspended in twice of the original volume in DSM medium (see 5.3.1.3). Growth 
of synchronised cells was performed at 310 K and 200 rpm. 
 
 
6.1.2.5 Induction of Endospore Formation in B. subtilis 
 
Sporulation of B. subtilis was induced by cultivation in nutrient-poor DSM medium (see 
5.3.1.3). Synchronised cells (see 6.1.2.4) were cultivated at 310 K and 200 rpm till 
designated cell state. The sporulation process usually starts ~ 3 h after onset of the 
stationary phase. Endospore formation usually accomplishes within ~ 8 h and 
endospores are visible by observation under a light microscope appearing as light 
diffracting cell compartments. 
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6.1.2.6 Determination of Cell Density 
 
Cell densities of E. coli and B. subtilis cultures in liquid medium were determined 
photometrically by measurement of the optical density (OD) at 600 nm wavelength 
using a UV-VIS spectrophotometer. High OD600 readings were calculated by diluting the 
sample in culture medium to enable measurement in the linear range of 0.1 -
 0.5 OD600. 
 
 
6.1.2.7 Growth Curve of Bacteria in Liquid Cultures 
 
For growth phase determination of bacteria in liquid cultures, samples were taken from 
incubating cultures in periodic intervals and treated as described in 6.1.2.6. Collected 
data were illustrated as a growth curve in logarithmic scale. 
 
 
6.1.2.8 Staining of Endospores  
 
Staining of B. subtilis endospores was performed accordingly to Rakette (Winkle, 1979). 
In this procedure, a drop of B. subtilis liquid culture in DSM was transferred to a 
microscope slide, dried on air, and heat-fixed. The slide was covered with malachite 
green solution (see 5.3.3) and heated near to boiling. The solution was kept hot for 
about 10 min without drying up. Malachite green solution was added if necessary. The 
slide was thoroughly washed-up with ddH2O and counterstained with eosine (see 5.3.3) 
for 5 min. The stain was washed away with ddH2O and the slide air-dried. Analysis was 
done in a bright field microscope with 40x objective and oil immersion. Endospores are 
stained in green while remaining cells appear red because of eosine incorporation. As 
a negative control, B. subtilis cells were cultivated in a non-sporulation medium (LB 
medium), treated as described, and analysed. 
 87
Methods 
6.2 Protein Chemistry 
 
 
6.2.1 Heterologous Overexpression of Proteins in E. coli 
 
E. coli BL21 Star (DE3) cells for protein overexpression (see 6.1.2.1) were cultivated at 
310 K and 200 rpm in TB medium containing 50 µg*ml-1 kanamycin. Induction of 
protein overexpression was performed at OD600 ~ 0.7 with 1 mM IPTG (isopropyl-1-thio-β-
D-galactopyranoside). The overexpression of recombinant proteins was accomplished 
in 4 h. The cells were harvested by centrifugation at 15900*g for 20 min at 277 K. Cell 
pellets which were not further processed subsequently, were stored at 193 K.  
 
 
6.2.2 Purification of His-tagged Proteins from E. coli under Native Conditions 
 
The purification procedure was done following the protocol of Dr. Sergej Djuranovic, MPI 
of Developmental Biology, Tübingen* (Djuranovic, 2007) which was, with minor 
modifications, based on the Qiagen manufacturer´s protocol (see 9.). 
The cell pellet was resuspended in NB 1 (see 5.3.2) and lysis enforced performing the 
French press method twice. DNase was added to digest DNA and to decrease the 
viscosity of the suspension. After removal of the insoluble cell particles by centrifugation 
(48400*g, 1 h, 277 K), the lysate was incubated with Ni-NTA material (Ni-NTA Superflow, 
Qiagen) pre-equilibrated with NB 1. Coupling of the His6-tagged protein to the Ni-NTA 
matrix was achieved via batch-incubation at room temperature for 30 min by gentlly 
end-over-end rotation. The suspension was transferred into an empty XK 
chromatography column and at this stage connected to the ÄKTA system (Amersham 
Biosciences). Unspecifically bound contaminants were removed by extensive washing 
with NB 2 (see 5.3.2) (~ 10 column volumes). The immobilised His6-tagged protein was 
eluted with NB 3 (see 5.3.2) in 3 ml fractions by applying a gradient within a range of 30 
column volumes. 10 µl of each of the eluted fractions were tested with respect to 
protein content and quality by SDS-PAGE (see 6.2.6). Fractions containing the desired 
protein were pooled. Buffer exchange, if required, was done by dialysis (see 6.2.10) 
against suitable buffers. 
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6.2.3 Generation of Polyclonal Rabbit Antibodies 
 
Prior to immunisation of the rabbit, a stable emulsion between the aqueous antigen 
solution (SpoVTFL) and the adjuvant was prepared. 0.5 ml of the two-step purified His6-
tagged SpoVTFL protein with a concentration of 2.31 mg*ml
-1 in 1x PBS buffer (see 5.3.2) 
were mixed with 0.5 ml of “Titermax Gold” adjuvant (Sigma). Thereby, the protein 
solution was added to the Titermax solution so that the aqueous phase entered the oil 
phase. This was done in two stages using each half of the amount of the protein 
solution for mixing with the adjuvant. 1 min of extensive mixing caused a sudden 
increase of the viscosity of the white coloured emulsion. For vigorously mixing, the 
double hub needle method was applied. The stability of the water-in-oil emulsion was 
tested by placing a drop of emulsion on water. A blood sample of ~ 1 ml was taken 
from the rabbit (pre-serum) and the emulsion was injected to induce the first 
immunisation reaction (day 1). 
To gain the serum from the blood, the blood was stirred with a glass rod for ~ 1 min and 
left at room temperature for 1 h. The blood was stirred again, cooled at 277 K 
overnight, stirred once more, and centrifuged for 30 min at 5000*g. The supernatant 
was collected, aliquoted, and the serum was stored at 253 K. 
A blood sample of the rabbit was taken at day 44 and prepared as described above. 
Immediately, the second immunisation was done with an emulsion prepared as 
described above using “Freundsches adjuvant incomplete” (Sigma) instead of “Titermax 
Gold”. At day 54, another blood sample was taken from the rabbit and treated as 
described. The third immunisation was carried out, comparably to the second 
immunisation procedure, at day 77 and again a blood sample was taken before 
injection. The serum for testing the titer was derived from the blood sample taken at day 
89 which was prepared as described. To test the titer, immuno blots were carried out 
with several amounts of antigen and serial dilutions of the serum (1:100 – 1:5000). Due 
to a good titer, the terminal blood of the rabbit was obtained at day 99. A volume of 
~ 35 ml rabbit blood was treated as described to gain the serum. The serum was 
aliquoted and stored at 253 K. 
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6.2.4 Purification of Polyclonal Antibodies 
 
Antibody isolation of the rabbit blood serum was performed via the Affi-Gel method 
(Bio-Rad). The activation procedure of the gel support was performed, with minor 
alterations, according to manufacturer´s protocol (see 9.). The antigen (SpoVTFL protein) 
was coupled to the N-hydroxysuccinimide ester of a derivatised crosslinked agarose 
(Affi-Gel). In this method, best binding properties are achieved at a pH near or below 
the isoelectric point of the protein. Here, Affi-Gel 15 was used which facilitates binding 
of acidic proteins (isoelectric point below 6.5, pI of SpoVTFL: 5.46). Coupling of the 
protein was carried out in 1x PBS buffer. 
4 ml of the thawed blood serum were buffered with AB 1 (see 5.3.2) to a final molarity of 
10 mM. After centrifugation (10 min, 3220*g), the supernatant was incubated with the 
activated Affi-Gel. Antigen-antibody interaction occurred in 1 h at 277 K by end-over-
end rotation. The slurry was poured into an empty chromatography column (Glass 
Eono-column column, Bio-Rad) to perform gravity flow chromatography. The flow 
through (serum) was added once more, followed by three washing steps with AB 2 (see 
5.3.2), three washing steps with AB 3 (see 5.3.2), and three washing steps with 1x PBS 
buffer (see 5.3.2). Fractional elution of the antigen-antibody complex was induced via a 
pH-shift by application of 5 column volumes 100 mM glycine solution pH 2.8. 
Subsequently, the eluates were bufferd with AB 4 (see 5.3.2) to a final molarity of 
10 mM. The fractions were checked for antibody content by SDS-PAGE analysis (see 
6.2.6). Protein positive fractions were pooled and dialysed against 1x PBS at 277 K 
overnight (see 6.2.10). The buffer was exchanged and dialysis was continued for 1 h. 
The antibody solution was aliquoted and stored at 253 K. 
 
 
6.2.5 Fast Cell Lysis for Determination of Protein Content 
 
To determine the protein inventory of E. coli and B. subtilis cells, 100 µl samples were 
taken from liquid cultures at a definite point in time. The cells were pelleted by 
centrifugation at 10000*g for 10 min and lysed by adding 10 µl of 5x SPB 1 (see 5.3.2). 
The samples were boiled for 7 min, centrifuged for 2 min, and analysed by SDS-PAGE 
(see 6.2.6). 
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6.2.6 SDS-Polyacrylamide Gel Electrophoresis 
 
Protein analysis regarding molecular mass, quality, purity, and even quantity is provided 
by an SDS-PAGE (sodium dodecylsulfate polyacrylamide gel electrophoresis) 
experiment. A discontinuous buffer system was used and SDS-PAGE performed under 
denaturing conditions referred to Laemmli (Hames, 1990). Gels were prepared with a 
content of 13% or 17% acrylamide for the separating gels and 7.5% for the stacking 
gels. 
 
A batch of 10 gels was prepared as follows: 
 
• Stacking gel 7.5%: 13.1 ml 30% Protogel, 13.1 ml SPB 3 (see 5.3.2), 250 µl ammonium-
persulfate, 50 µl TEMED, 26.25 ml ddH2O 
• Separating gel 13%: 32.5 ml 30% Protogel, 18.75 ml SPB 2 (see 5.3.2), 250 µl ammonium-
persulfate, 50 µl TEMED, 23.75 ml ddH2O 
• Separating gel 17%: 42.5 ml 30% Protogel, 18.75 ml SPB 2 (see 5.3.2), 250 µl ammonium-
persulfate, 50 µl TEMED, 13.75 ml ddH2O. 
 
Polymerised gels were clamped into Mighty Small II units (Amersham Biosciences) and 
covered with 1x SPB 4 (see 5.3.2). 1x or 5x SPB 1 (see 5.3.2) was added to the protein 
samples and after boiling for max. 10 min, the samples and a protein molecular weight 
marker (Fermentas) were filled into the wells of the stacking gel. Electrophoresis was 
carried out under constant cooling at 200 V and 40 - 80 mA using an electrophoresis 
power supply (Pharmacia Biotech). After the electrophoresis run, the proteins were fixed 
and the gels stained in a Coomassie suspension (see 5.3.3) for ~ 45 min. Destaining 
(see 5.3.3) of the gels was performed till distinct protein bands became visible. 
 
Commercially available Bis-Tris polyacrylamid gradient gels (NuPAGE, Invitrogen) were 
also in use. Electrophoresis was performed according to manufacturer´s protocol (see 
9.). 
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6.2.7 Native Polyacrylamide Gel Electrophoresis 
 
Native polyacrylamide gel electrophoresis (NativePAGE, Invitrogen) using pre-cast gels 
was done corresponding to manufacturer´s protocol (see 9.). 
 
 
6.2.8 Electro Blotting 
 
Electro blotting is a method for an electrochemical transfer of denatured proteins from 
a polyacrylamide gel onto a solid support. Here, the semi-dry blotting technique was 
applied. The solid support was provided by a PVDF membrane (Immobilon-P, Millipore). 
The membrane was activated by incubation in methanol for 15 sec. The protein 
samples of interest were separated in a polyacrylamide gel by running a SDS-PAGE (see 
6.2.6). Afterwards, the gel and the membrane were overlied and packed in a batch of 
buffer-moist Whatman paper sheets. The proteins in the electric field move from the 
cathode to the anode. The pack was arranged as: 
 
Cathode - 
4 pieces of Whatman sheets in EB 3 
Gel in EB 3 
Membrane in EB 2 
2 pieces of Whatman sheets in EB 2 
4 pieces of Whatman sheets in EB 1 
Anode + 
 
The block was clamped between two electrode plates of a home-made device. The 
transfer was enforced in ~ 2.5 h at room temperature and 30 mA provided by a power 
supply (Pharmacia Biotech). 
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6.2.9 Immuno (Western) Blotting 
 
Western Blot analysis is a very specific and sensitive immunological method of protein 
identification. For this, proteins of interest were transferred from a polyacrylamide gel 
onto a solid support via electro blotting as described in 6.2.8. To check the efficiency of 
the protein transfer, the membrane was stained with a Ponceau S solution (see 5.3.3) for 
30 sec and transferred protein bands became visible. The stain was thoroughly washed 
away with ddH2O. The membrane was treated with WB 1 (see 5.3.2) two times for 
10 min each. For blocking, the membrane was incubated in WB 2 at room temperature 
for 3 h by end-over-end rotation. Unbound BSA was washed away with WB 3 (10 min) 
and WB 1 (2 times, 10 min each). The primary antibody (polyclonal rabbit IgG, see 
6.2.4) was applied in a 1:10000 dilution in WB 2 by overnight end-over-end rotation at 
277 K. Accurately washing in WB 1 (several times) was performed prior to adding the 
secondary antibody (goat anti-rabbit IgG, horseradish, Sigma, 1:50000 dilution in WB 2). 
Incubation was done for 1 h at 277 K by end-over-end rotation. The membrane was 
washed several times in WB 1, covered with a 1:1 mixed luminol/H2O2 reaction solution 
(Pierce) and incubated for 3 min (see 9.). Protein bands which were specifically 
recognised by the polyclonal rabbit anitbody became visible by subsequently exposing 
the membrane to X-ray films. Exposure was done several times for different time periods 
and the films were developed by standard film developing methods. 
 
 
6.2.10 Dialysis 
 
The removal of low molecular components of protein solutions and/or exchange of the 
medium was done by dialysis. Dialysis tubes (Sigma) or cassettes (Pierce) made up of a 
semi-permeable cellulose membrane with a specific cut-off were filled with a protein 
solution and transferred into the desired medium. Substances of smaller size than the 
cut-off passed the membrane and by-and-by, conditions within the dialysis tube or 
cassette adapted to the surrounding solution. In normal case, dialysis was carried out at 
277 K overnight. Tubes and cassettes were treated as described by manufacturer´s 
protocol (see 9). 
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6.2.11 Ultrafiltration 
 
Enhancement of protein concentration was performed by the ultrafiltration method. 
Specific cut-off membranes in pre-cast devices (Amicon, Millipore) hinder proteins of 
equivalent and larger sizes to pass the membrane. Smaller proteins and molecules can 
cross the membrane by an applied centrifugal force. The procedure was done 
according to manufacturer`s protocol (Millipore, see 9.). 
 
 
6.2.12 Determination of Protein Concentration 
 
 
6.2.12.1 UV Absorption 
 
The concentration of protein solutions was determined by spectroscopic methods at a 
wavelength of 280 nm using an UV-Vis spectrometer or a spectrophotometer 
(NanoDrop). Light absorption of proteins is mainly caused by the presence of the 
aromatic amino acids tyrosine (Tyr) and tryptophane (Trp). Based on the extinction 
coefficient of the protein which was computed using the equation 
 
ε(protein) = n(Tyr)* ε(Tyr) + n(Trp)* ε(Trp), 
(ε(Tyr) = 1490, ε(Trp) = 5500 at 280 nm in aqueous solution)§, 
 
the protein concentration was calculated with respect to Lambert Beer´s law 
 
E = ε * d * c 
 
(ε = extinction coefficient, n = number of amino acids, E = extinction, d = path length, c = 
concentration of protein). 
                                                 
§ http://www.expasy.ch/tools/protparam-doc.html 
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6.2.12.2 BCA Protein Essay 
 
Alternatively, protein concentration determination was done by the BCA (bicinchoninic 
acid) assay. Based on the biuret reaction, in which proteins reduce Cu2+ ions under 
alkaline conditions, a purple coloured complex between emerging Cu+ ions and BCA 
(Pierce) is formed. Distinct protein dilutions were measured colourimetrically at 562 nm 
using an UV-Vis spectrometer after completion of the reaction. Protein concentrations 
were calculated by a standard curve. The experimental setup was done following 
manufacturer´s protocol (Pierce, see 9.). 
 
 
6.2.13 Chemical Crosslinking 
 
The bifunctional agent glutaraldehyde is commonly used for conjugation of proteins. 
Glutaraldehyde induces intra- and intermolecular interactions via formation of Schiffs 
bases using the primary amino groups especially of lysines. Such covalently linked 
protein complexes can be analysed by SDS-PAGE. 
Crosslinking of SpoVTFL and SpoVTCT was done each with ~ 60 µg of protein and 0.025% 
glutaraldehyde in 20 µl reaction batches. Samples were incubated for 10 min at 303 K 
and subsequently, 20 µl of SPB 1 were added. 10 µl were applied to SDS-PAGE analysis 
(see 6.2.6). 
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6.3 Biochemistry 
 
 
6.3.1 Chromatography 
 
 
6.3.1.1 Affinity Chromatography 
 
The initial protein purification step was performed by affinity chromatography with a Ni-
chelating material (Ni-NTA superflow, Qiagen) (see 6.2.2) or Affi-Gel (see 6.2.4). In metal 
affinity chromatography, sepharose beads with exposed functional NTA (nitrilotriacetic 
acid) groups and complexed Ni-atoms, which are able to specifically immobilise His-
tagged proteins, were used (IMAC). For specifications of the Affi-Gel see 6.2.4. Protein 
purification procedures were carried out, with minor alterations, based on 
manufacturer´s protocol (Bio-Rad, see 9.). 
Batch-incubation of cell lysate with pre-equilibrated Ni-NTA material for purification of 
His6-tagged proteins was followed by an application to an HPLC system for an 
automated protein purification process. Batch-incubation and the gravity flow method 
were used for purifying polyclonal antibodies. Elution of His-tagged proteins was 
induced by adding high amounts of imidazole or EDTA, or applying a pH-shift. The latter 
was used for elution of polyclonal antibodies. 
 
 
6.3.1.2 Gel Filtration Chromatography 
 
Preparative gel filtration chromatography was performed as a second protein 
purification step to achieve a higher degree of purity. A HiLoad 26/60 Superdex 75 
prepgrade column (Amersham Biosciences) with a separation range for proteins of a 
molecular weight between 3 kDa and 70 kDa was used. Binding studies (analytical gel 
filtration chromatography) were done using the SMART chromatography system 
(Amersham Biosciences) and a gel filtration column Superdex 75 PC 3.2/30 (Amersham 
Biosciences). At a flow rate of 40 µl*min-1, ~ 45 µl of a protein solution with a 
concentration of 1.5 mg*ml-1 for SpoVTFL and 3 mg*ml
-1 for SpoVTCT, incubated with 
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10 mM of potential binding partners, were analysed. For calibration, proteins of a 
definite mass were applied (LMW calibration kit, Amersham Biosciences, see 9.). Gel 
filtration chromatography experiments were done in MOPS buffer (see 5.3.2) following 
manufacturer´s protocols (Amersham Biosciences, see 9.). 
 
 
6.3.2 High Performance Liquid Chromatography/Mass Spectrometry 
(HPLC/MS) 
 
High performance liquid chromatography/mass spectrometry (HPLC/MS) was done for 
exact mass analysis of proteins. Protein solutions were separated on a reversed phase 
column (Waters Symmetry C4 column, particle size 3.5 µm - stationary phase) in an 
aqueous solution (mobile phase). 
After ionisation of the sample, emerging free ions were analysed concerning their 
mass/charge ratio (m/z) and converted into a mass spectrum. 
 
 
6.3.3 Matrix Assisted Laser Desorption Ionisation/Time of Flight/Mass 
Spectrometry (MALDI/TOF/MS) 
 
Identification of proteins was done by matrix assisted laser desorption ionisation/time of 
flight/mass spectrometry (MALDI/TOF/MS). In this method, purified proteins are checked 
regarding their amino acid sequence by laser beam based ionisation out of a 
condensed phase. 
Slices of Coomassie stained protein bands in a polyacrylamide gel (see 6.2.6) were 
excised and digested with trypsin. Generated peptides were mixed with a specific 
matrix material for protection against direct exposure to the laser beam. After 
evaporation of the sample, the crystalline mixture was applied to the MS system. 
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6.3.4 N-terminal Amino Acid Sequencing 
 
Alternatively, identity of proteins was checked by the N-terminal sequencing method. 
Proteins were transferred onto a solid support (PVDF membrane) by electro blotting (see 
6.2.8). The membrane was incubated in a Coomassie solution (see 5.3.3) until distinct 
protein bands became visible. Slices of the protein bands were excised and the Edman 
degradation technique was applied for successive determination of the primary 
structure of the proteins. 
 
 
6.3.5 Limited Proteolysis 
 
Limited proteolysis was done with trypsin and α-chymotrypsin. Reaction batches 
contained 84 µg of the protein (either SpoVTFL or SpoVTCT), 10 mM of the potential 
ligand, 10 mM CaCl2 in the case of DPA as ligand candidate, and either 0.26 µg trypsin 
or 0.52 µg α-chymotrypsin. 120 µl of LPB 1 (see 5.3.2) were added to trypsin containing 
samples and 120 µl of LPB 2 (see 5.3.2) were added to samples including α-
chymotrypsin, resulting in final batch volumes of ~ 150 µl each. For DNA-binding tests, 
4 µg DNA (promoter region of SpoVT operon, see 6.1.1.1) were included into the batch 
mixture. As a control, BSA was used in every variation of the experiment in the same 
amount compared to the analytical protein. The samples were incubated at 298 K with 
slightly shaking. At different points in time (0, 5, 10, 20, 30, 60, and 120 min), 20 µl of the 
reaction solutions were mixed with 20 µl of 1x SPB 1 (see 5.3.2), boiled, and analysed by 
SDS-PAGE (see 6.2.6). 
 
 
6.3.6 Preparation of B. subtilis Spores 
 
B. subtilis cells were removed from liquid sporulation culture at definite time points. The 
cells were pelleted at 3220*g for 10 min, medium was removed by decanting, and the 
pellet was washed once with SB 1 (see 5.3.2). The pellet was suspended in SB 2 (see 
5.3.2) and incubated at room temperature for 10 min. After a centrifugation step, the 
pellet was washed repeatedly with SB 3 (see 5.3.2) at room temperature. For following 
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SDS-PAGE analysis (see 6.2.6), the extant pellet was solubilised in 0.1 ml SPB 1 (see 5.3.2) 
and boiled at 372 K for 10 min. 
Alternatively, purified spores were resuspended in ddH2O and pelleted by centrifugation 
for 6 min. The spores were suspended in SB 4 (see 5.3.2) and incubated at 310 K for 
20 min. The sample was centrifuged for 6 min and using the pellet, the extraction 
procedure was repeated. Both supernatants were pooled, mixed with SPB 1, (see 5.3.2) 
boiled, and analysed by an SDS-PAGE (see 6.2.6). 
 
 
 
6.4 Molecular Biophysics 
 
 
6.4.1 X-ray Crystallography 
 
 
6.4.1.1 Protein Crystallisation, Soaking, Co-crystallisation, and Seeding 
 
The equipment for perfoming 3D-crystallisation was purchased from Hampton 
Research. 
 
For 3D-crystallisation trials, the protein concentration was adjusted to a certain final 
concentration via ultrafiltration (see 6.2.11). 
Proteins were crystallised by vapour diffusion in hanging drops of 5 µl volume against 
500 µl reservoir solution at 291 K. Drops contained a 1:1 volume ratio of 10 mg*ml-1 or 
20 mg*ml-1 protein in MOPS and crystallisation buffer. Crystallisation conditions were 
screened with commercially available reagents (Hampton Research, Sigma, Jena 
Biosciences, Emerald BioSystems). Optimisation of the initial crystallisation conditions, if 
necessary, was performed by providing additives (Hampton Research, Additive screen). 
2.5 µl of the protein solution were mixed with 2 µl of the crystallisation condition buffer 
and 0.5 µl of additive solution. 
 
Drops with existing crystals were used for testing the ligand binding property of SpoVT via 
soaking. Therefore, 0.1 µl of solutions containing potential binding partners (cGMP, 
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isoleucine, and DPA) were added to the drop to a final content of 10 mM. Diffusion of 
the small molecules enables its association to the protein and probably specific binding 
to the protein binding site occurs. Several days of incubation under known conditions 
followed. 
Another way of performing binding studies is provided by co-crystallisation. The protein 
and the putative binding partner are incubated prior to preparation of the crystallisation 
trials. Protein solutions of SpoVTCT were mixed with solutions of cGMP, GTP, or isoleucine 
to a final content of 10 mM of potential ligand. To SpoVTFL protein solutions, a DNA 
fragment defining the promotor sequence of SpoVT was added (see 6.1.1.1) in each 
case. Crystallisation trials of the protein solutions were carried out by hanging drop 
vapour diffusion (see above). 
 
A method for crystal multiplication is described by seeding. In performing the 
micorseeding technique, existing crystals are carefully touched by a whisker which picks 
up seeds from the crystal. The whisker is streaked in a pre-equilibrated drop (SpoVTCT 
protein solution together with crystallisation solution MSB, see 5.3.2) and at most, the 
crystals grow along the streak line. 
 
 
6.4.1.2 Crystal Mounting and Data Collection 
 
For data collection, single crystals were mounted using cryo-crystallography tools from 
Hampton Research. Synthetic pre-mounted cryoloops of suitable size (0.025 - 0.4 mm) 
were used for removing crystals from the drops. Mounted SpoVTFL crystals were frozen 
directly in liquid nitrogen. Crystals of SpoVTCT and its Se-Met derivate were treated with 
mother solution containing 5% (v/v) PEG 200 for cryo-protection prior to freezing. The 
mounted crystals were stored in liquid nitrogen. 
Diffraction data were collected at the Swiss Light Source (SLS) beamline PXII X10SA at the 
Paul Scherrer Institut (PSI) in Villigen, Switzerland. The data were recorded on a standard 
mar225 CCD detector featuring an active area of 225 x 225 mm². Image data were 
collected at 100 K at wavelengths of 0.978 Å for SpoVTFL and 0.979 Å for the SpoVTCT 
crystals. Data sets of 280° with an oscillation range of 1° were collected. For the SpoVTCT 
Se-Met derivate, a single anomalous dispersion (SAD) experiment was performed and 
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data were collected at the selenium absorption edge (0.979 Å). Prior to data collection, 
a fluorescence scan was obtained to detect the absorption maximum of the selenium. 
 
 
6.4.1.3 Data Processing and Phasing 
 
Direct structure determination of crystals is based on an anomalous dispersion of X-ray 
scattering factors. For phase determination, isomorphous (MIR, multiple isomorphous 
replacement) and anomalous (MAD, multiwavelength anomalous dispersion) methods 
are used. The endogenous anomalous scatterer selenium was incorporated into 
SpoVTCT to replace methionine with seleno-methionine for phase determination by 
selenium-based MAD phasing (SAD) (Hendrickson et al., 1990). 
The SAD data of the Se-Met SpoVTCT crystal were integrated, merged and scaled using 
the programme XDS/XSCALE (Kabsch, 1993). Intensity data were converted into 
amplitudes using TRUNCATE (French and Wilson, 1978). Six Se sites were located and 
experimental phases were calculated at 2.1 Å resolution using SOLVE/RESOLVE 
(Terwilliger, 2000; Terwilliger and Berendzen, 1999). 
Data of native SpoVTFL and SpoVTCT protein crystals were processed as described above. 
The SpoVTFL structure was determined by molecular replacement in MOLREP (Vagin and 
Teplyakov, 1997) using the SpoVTCT model as search model (1.5 Å, R/Rfree 19.7% and 
22.6%, respectively). 
 
 
6.4.1.4 Model Building and Refinement 
 
For SpoVTCT, a partial model was built automatically with RESOLVE (Terwilliger, 2003) and 
the remainder of the protein was built manually. The initial model was further refined by 
several cycles of model rebuilding with COOT (Emsley and Cowtan, 2004) and 
automatic refinement using REFMAC (Murshudov et al., 1997). Solvent waters were 
added using the automated ARP/wARP programme (Perrakis et al., 2001). 
The refined model of SpoVTCT was used as search model for solving the structure of 
SpoVTFL by molecular replacement (see 6.4.1.3). To improve the density of the N-
terminal domain, which could not be placed by molecular replacement using one 
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chain of the NMR-structure of the N-terminal domain of AbrB (PDB entry 1YFB), the prime-
and-switch routine of the RESOLVE programme was applied. The structure of SpoVTFL was 
completed by density fitting the N-terminal part of AbrB into the solvent flattened map. 
Residues different between the N-termini of AbrB and SpoVT were exchanged and the 
model refined with non-crystallographic symmetry (NCS) restraints using iterative cycles 
of model building and refinement with COOT and REFMAC as mentioned above. The 
geometry was finally evaluated with PROCHECK (Laskowski et al., 1993). 
 
 
6.4.2 Circular Dichroism (CD) Spectroscopy 
 
Circular dichroism (CD) spectroscopy is a light absorption based method for analysis of 
the secondary structure of proteins. Thereby, the differences in the absorbance of right- 
and left-circularly polarized light by a substance are determined. Measurements were 
done on a J-715 spectropolarimeter (JASCO Corporation) with protein concentrations of 
145 µg*ml-1 for SpoVTFL and 165 µg*ml
-1 for SpoVTCT. Analyses were done in MOPS buffer. 
Determination of CD spectra was performed with 300 µl of the protein solutions in 8 
scans in the far-UV spectral region within the wavelength range of 195 nm to 260 nm. 
Heat denaturing experiments were determined in the range of 277 K up to 363 K and in 
the wavelength rage of 280 nm to 215 nm. The temperature was checked by an 
incorporated Peltier element controller (JASCO Corporation). 
 
 
6.4.3 Isothermal Titration Calorimetry (ITC) 
 
Isothermal titration calorimetry (ITC) is a method to study the binding of small molecules 
(ligands) to macromolecules (proteins) by determination of the thermodynamic 
parameters of the interaction. ITC experiments were performed to identify the ligand 
binding specifity of SpoVT. SpoVTFL and SpoVTCT in MOPS buffer were each tested 
regarding their binding specificity towards GTP, cGMP, isoleucine, and valine. 2 ml of a 
50 µM protein solution were titrated with 400 µl of a 1 mM solution containing the 
potential ligand. In the experimental progress, 50 titration steps, each of 360 sec 
duration, were passed at 293 K. 
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7. ABBREVIATIONS 
 
µg  microgram 
µl  microlitre 
µm  micrometre 
µmol  micromole 
3D  three-dimensional 
A  albumine 
Å  Angstrom 
AB  antibody purification buffer 
Abh  antibiotic resistance protein B 
  homolog 
AbhNT  N-terminal domain of  
  antibiotic resistance protein B 
  homolog 
AbrB  antibiotic resistance protein B 
AbrBNT  N-terminal domain of  
  antibiotic resistance protein B 
ADP  adenosine diphosphate 
AMP  adenosine monophosphate 
ATP  adenosine triphosphate 
B. globigii Bacillus globigii 
B. subtilis Bacillus subtilis 
BCA  bicinchoninic acid 
BCAA  branched-chain amino acid 
BglI  Bacillus globigii type II 
restriction endonuclease I 
b. i. before induction 
bp base pair 
BSA  bovine serum albumine 
C  Celsius, C-terminus 
CL  cell lysate 
cAMP  cyclic adenosine  
  monophosphate 
CCD  charge-coupled device 
CD  circular dichroism 
cGMP  cyclic guanosine  
  monophosphate 
cm  centimetre 
CodY  cytosine deaminase Y 
CodYNT  N-terminal domain of cytosine 
  deaminase Y 
coxA  cortex protein A gene 
csgA  controlled by sigma G protein 
A gene 
CT A  chymotrypsinogen A 
cyaB2  adenylate cyclase GAF-B2 
gene 
cyaB2CT  C-terminal part of adenylate 
cyclase GAF-B2 gene product 
DBD  DNA-binding domain 
ddH2O  double distilled water 
dmol  dezimole 
DMSO  dimethylsulfoxide 
DNA  desoxyribonucleic acid 
DPA  dipicolinic acid 
DSM  Difco sporulation medium 
DMSO  dimethylsulfoxide 
DTT  dithiothreitol 
E  SpoVTFL monomer with 
elongated linker 
E. coli  Escherichia coli 
EB  electro blotting buffer 
EDTA  ethylenedinitrilotetraacetic 
  acid 
Escherichia coli FhlA 
e.g.  for example 
ESI  electro spray ionisation 
FhlA  formate hydrogen lyase A 
FT  flow through 
GA  glutaraldehyde 
GAF  cGMP-specific and 
 -stimulated phosphodi-
 esterases, Anabaena 
adenylate cyclases, and  
GerE  germination protein E 
GroEL  growth protein EL 
GTP  guanosine triphosphate 
h  hour 
HEPES  4-(2-hydroxyethyl)-1- 
  piperazineethanesulfonic acid 
HLH  helix-loop-helix 
HMM  Hidden Markov model 
hmp  haemoglobin-like protein 
gene 
HPLC  high pressure liquid  
  chromatography 
HTH  helix-turn-helix 
IclR  isocitrate lyase regulator 
IclRCT  C-terminal domain of  
  isocitrate lyase regulator 
i.e.  that is 
IgG  immunoglobulin G 
IMAC  immobilised metal affinity 
chromatography 
IPTG  isopropyl-1-thio-β-D- 
  galactopyranoside 
ITC  isothermal titration calorimetry 
K  Kelvin 
Kan  kanamycin 
kcal  kilocalorie 
kDa  kilodalton 
keV  kiloelectron volt 
kT/e  25.6 mV, 0.593 kcal/mole at 
  25 °C 
l  litre 
L  load 
LB  Luria Bertani 
LC  liquid chromatography 
LM  light microscope 
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LMW  low molecular weight 
LPB  limited proteolysis buffer 
M  molar; molecular weight 
marker 
m/z  mass per charge ratio 
mA  milliampere 
MAD  multiwavelenght anomalous 
  dispersion 
MALDI  matrix assisted laser desorption 
  ionisation 
MazE  ma-ze (“what is it?”) 
MazENT  N-terminal domain of ma-ze 
mdeg  millidegree 
mg  milligram 
min  minute 
MIR  multiple isomorphous  
  replacement 
ml  millilitre 
mm  millimetre 
mM  millimole 
MOPS  3-(N-morpholino)  
  propanesulfonic acid 
MPI  Max Planck Institute 
MraZ  murein region A protein Z 
MS  mass spectrometry 
MSB  microseeding buffer 
mV  millivolt 
N  N-terminus 
NB  Ni-NTA buffer 
NCS  non-crystallographic symmetry 
ng  nanogram 
nm  nanometre 
NMR  nuclear magnetic resonance 
No.  number 
NTA  nitrilotriacetic acid 
OA  ovalbumine 
OD  optical density 
PAGE  polyacrylamide gel  
  electrophoresis 
PBS  phosphate buffer solution 
PCR  polymerase chain reaction 
PDB  protein data bank 
PDE  phosphodiesterase 
PEG  polyethyleneglycol 
PFAM  protein family 
pI  isoelectric point 
pmol  picomole 
PSI  Paul Scherrer Institute 
r.m.s.d.  root mean square deviation 
RNA  ribonucleic acid 
RNAP  ribonucleic acid polymerase 
rpm  rounds per minute 
RsfA  sigma F regulator A 
S  SpoVTFL monomer with 
structured linker 
SAD  single anomalous dispersion 
SASP  small acid-soluble spore 
protein 
SB  spore buffer 
SDS  sodium dodecylsulfate 
Se  selenium 
sec  second 
Se-Met  seleno-methionine 
SFT  SpoVTFL flow through 
sleB  spore cortex-lytic enzyme B 
gene 
SLS  Swiss Light Source 
SMBD  small-molecule-binding 
domain 
SPB  SDS-PAGE buffer 
Spo0A  stage 0 sporulation protein A 
SpoIIID  stage III sporulation protein D 
SpoVT  stage V sporulation protein T 
SpoVTCT  C-terminal domain of stage V 
  sporulation protein T 
SpoVTFL  full-length stage V sporulation 
  protein T 
SpoVTNT  N-terminal domain of stage V 
  sporulation protein T 
SSD  signal sensing domain 
SW  SpoVTFL wash 
T  temperature 
T2.5  time of highest SpoVT 
expression level 
TAD  trans-activation domain 
TB  terrific broth 
TCA  trichloricacetic acid 
TEMED  N,N,N’,N’-tetramethyl  
  ethylenediamine 
TLS  twin lattice symmetry 
TM  Thermotoga maritima 
Tm, TM  melting temperature 
TOF  time of flight 
TraR  transcriptional activator protein 
  R 
Tris  tris (hydroxymethyl)  
  aminomethane 
UV  ultraviolet 
UV-Vis  ultraviolet and visible 
V  Volt 
v/v  volume per volume 
W  wash 
WB  western blotting buffer 
w/v  weight per volume 
ZnF  Zinc-finger 
σ  sigma factor 
λ  wavelength 
θ  molar ellipticity 
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9. APPENDIX 
 
Amersham Biosciences: 
• Gel Filtration Column HiLoad 26/60 Superdex 75 prepgrade 
(http://www6.gelifesciences.com/aptrix/upp00919.nsf/Content/A729A28AA52A89
4CC1256EB400417EDB/$file/71502020AF.pdf) 
• Gel Filtration Column Superdex 75 PC 3.2/30 
(http://www6.gelifesciences.com/aptrix/upp00919.nsf/Content/BB42DD3E4A6C0D
15C1256EB40044A98B/$file/71606300AH.pdf) 
• Gel Filtration Calibration Kit 
(http://www6.gelifesciences.com/aptrix/upp00919.nsf/Content/94339EC8D376AF
11C12571BC00811DDA/$file/28-4038-41PL_Rev_B_2007_WEB.pdf) 
 
Bio-Rad: 
• Activated Immunoaffinity Support (Affi-Gel) 
 (http://www.bio-rad.com/webmaster/pdfs/9115_Activated_Affinity.pdf) 
 
Invitrogen: 
• Library Efficiency DH5α Competent Cells 
 (http://tools.invitrogen.com/content/sfs/manuals/18263012.pdf) 
• Champion pET Directional TOPO Expression Kit 
 (http://tools.invitrogen.com/content/sfs/manuals/pettopo_man.pdf) 
• NativePAGE Novex Bis-Tris Gel System 
 (http://tools.invitrogen.com/content/sfs/manuals/nativepage_man.pdf) 
• NuPAGE Technical Guide 
 (http://tools.invitrogen.com/content/sfs/manuals/nupage_tech_man.pdf) 
 
Millipore: 
• Amicon Ultra-4/15 Centrifugal Filter Devices 
(http://www.millipore.com/userguides.nsf/a73664f9f981af8c852569b9005b4eee/
b4dcbc6be6274e94852572c200701f88/$FILE/ATTY6HU4/PR02496A_web.pdf, 
 http://www.millipore.com/userguides.nsf/a73664f9f981af8c852569b9005b4eee/
a50b8057dc203885852572c2006ec963/$FILE/ATTWDFLK/PR02497A_web.pdf) 
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Pierce: 
• BCA Protein Assay Kit 
 (http://www.piercenet.com/files/1296as4.pdf) 
• ECL Western Blotting Substrate 
 (http://www.piercenet.com/files/1743as4.pdf) 
• Slide-A-Lyzer Dialysis Cassettes 
 (http://www.piercenet.com/files/0729dh5.pdf) 
 
Qiagen: 
• The QIAexpressionist 
 (http://www1.qiagen.com/HB/QIAexpressionist_EN) 
• QIAprep Miniprep Handbook 
 (http://www1.qiagen.com/HB/QIAprepMiniprepKit_EN) 
• QIAquick Spin Handbook 
 (http://www1.qiagen.com/HB/QIAquickSpinKit_EN_1) 
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